CINXE.COM
5α-Reductase inhibitor - Wikipedia
<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>5α-Reductase inhibitor - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy", "wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"15ae5d4b-3d2d-4c3e-a32a-89d2016f4e98","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"5α-Reductase_inhibitor","wgTitle":"5α-Reductase inhibitor","wgCurRevisionId":1262650612,"wgRevisionId":1262650612,"wgArticleId":1284673,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 German-language sources (de)","Articles with short description","Short description is different from Wikidata","5α-Reductase inhibitors","Hair loss medications","Hair removal","Antiandrogens"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"5α-Reductase_inhibitor","wgRelevantArticleId":1284673,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[], "wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":30000,"wgRelatedArticlesCompat":[],"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q4639645","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false ,"wgGELevelingUpEnabledForUser":false};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.tablesorter.styles":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.tablesorter","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init", "ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.growthExperiments.SuggestedEditSession"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cjquery.tablesorter.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&only=styles&skin=vector-2022"> <script async="" src="/w/load.php?lang=en&modules=startup&only=scripts&raw=1&skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&modules=site.styles&only=styles&skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.6"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/1200px-Dutasteride.svg.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="1111"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/800px-Dutasteride.svg.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="741"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/640px-Dutasteride.svg.png"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="593"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="5α-Reductase inhibitor - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/5%CE%B1-Reductase_inhibitor"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/5%CE%B1-Reductase_inhibitor"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&feed=atom"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-5α-Reductase_inhibitor rootpage-5α-Reductase_inhibitor skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span> <span class="vector-dropdown-label-text">Main menu</span> </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <span class="mw-logo-container skin-invert"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </span> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span> <span>Search</span> </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > <span class="cdx-text-input__icon cdx-text-input__start-icon"></span> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page's font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-appearance mw-ui-icon-wikimedia-appearance"></span> <span class="vector-dropdown-label-text">Appearance</span> </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/?wmf_source=donate&wmf_medium=sidebar&wmf_campaign=en.wikipedia.org&uselang=en" class=""><span>Donate</span></a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&returnto=5%CE%B1-Reductase+inhibitor" title="You are encouraged to create an account and log in; however, it is not mandatory" class=""><span>Create account</span></a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&returnto=5%CE%B1-Reductase+inhibitor" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o" class=""><span>Log in</span></a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span> <span class="vector-dropdown-label-text">Personal tools</span> </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/?wmf_source=donate&wmf_medium=sidebar&wmf_campaign=en.wikipedia.org&uselang=en"><span>Donate</span></a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&returnto=5%CE%B1-Reductase+inhibitor" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&returnto=5%CE%B1-Reductase+inhibitor" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"><!-- CentralNotice --></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> <div class="vector-sticky-pinned-container"> <nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark"> <div id="vector-toc-pinned-container" class="vector-pinned-container"> <div id="vector-toc" class="vector-toc vector-pinnable-element"> <div class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned" data-feature-name="toc-pinned" data-pinnable-element-id="vector-toc" > <h2 class="vector-pinnable-header-label">Contents</h2> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button> </div> <ul class="vector-toc-contents" id="mw-panel-toc-list"> <li id="toc-mw-content-text" class="vector-toc-list-item vector-toc-level-1"> <a href="#" class="vector-toc-link"> <div class="vector-toc-text">(Top)</div> </a> </li> <li id="toc-Medical_uses" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Medical_uses"> <div class="vector-toc-text"> <span class="vector-toc-numb">1</span> <span>Medical uses</span> </div> </a> <button aria-controls="toc-Medical_uses-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Medical uses subsection</span> </button> <ul id="toc-Medical_uses-sublist" class="vector-toc-list"> <li id="toc-Available_forms" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Available_forms"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.1</span> <span>Available forms</span> </div> </a> <ul id="toc-Available_forms-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Side_effects" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Side_effects"> <div class="vector-toc-text"> <span class="vector-toc-numb">2</span> <span>Side effects</span> </div> </a> <button aria-controls="toc-Side_effects-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Side effects subsection</span> </button> <ul id="toc-Side_effects-sublist" class="vector-toc-list"> <li id="toc-Sexual_dysfunction" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Sexual_dysfunction"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.1</span> <span>Sexual dysfunction</span> </div> </a> <ul id="toc-Sexual_dysfunction-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Breast_changes" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Breast_changes"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.2</span> <span>Breast changes</span> </div> </a> <ul id="toc-Breast_changes-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Emotional_changes" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Emotional_changes"> <div class="vector-toc-text"> <span class="vector-toc-numb">2.3</span> <span>Emotional changes</span> </div> </a> <ul id="toc-Emotional_changes-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Pharmacology" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Pharmacology"> <div class="vector-toc-text"> <span class="vector-toc-numb">3</span> <span>Pharmacology</span> </div> </a> <ul id="toc-Pharmacology-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-History" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#History"> <div class="vector-toc-text"> <span class="vector-toc-numb">4</span> <span>History</span> </div> </a> <ul id="toc-History-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Research" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Research"> <div class="vector-toc-text"> <span class="vector-toc-numb">5</span> <span>Research</span> </div> </a> <ul id="toc-Research-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-See_also" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#See_also"> <div class="vector-toc-text"> <span class="vector-toc-numb">6</span> <span>See also</span> </div> </a> <ul id="toc-See_also-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-References" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#References"> <div class="vector-toc-text"> <span class="vector-toc-numb">7</span> <span>References</span> </div> </a> <ul id="toc-References-sublist" class="vector-toc-list"> </ul> </li> </ul> </div> </div> </nav> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left" > <input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span> <span class="vector-dropdown-label-text">Toggle the table of contents</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">5α-Reductase inhibitor</span></h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 8 languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-8" aria-hidden="true" ><span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span> <span class="vector-dropdown-label-text">8 languages</span> </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D9%85%D8%AB%D8%A8%D8%B7_%D9%85%D8%AE%D8%AA%D8%B2%D9%84%D8%A9_%D8%A7%D9%84%D8%A3%D9%84%D9%81%D8%A7-5" title="مثبط مختزلة الألفا-5 – Arabic" lang="ar" hreflang="ar" data-title="مثبط مختزلة الألفا-5" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D9%85%D9%87%D8%A7%D8%B1%DA%A9%D9%86%D9%86%D8%AF%D9%87_5%CE%B1-%D8%B1%D8%AF%D9%88%DA%A9%D8%AA%D8%A7%D8%B2" title="مهارکننده 5α-ردوکتاز – Persian" lang="fa" hreflang="fa" data-title="مهارکننده 5α-ردوکتاز" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/5%EC%95%8C%ED%8C%8C-%ED%99%98%EC%9B%90%ED%9A%A8%EC%86%8C_%EC%A0%80%ED%95%B4%EC%A0%9C" title="5알파-환원효소 저해제 – Korean" lang="ko" hreflang="ko" data-title="5알파-환원효소 저해제" data-language-autonym="한국어" data-language-local-name="Korean" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%9E%D7%A2%D7%9B%D7%91%D7%99_5-%D7%90%D7%9C%D7%A4%D7%90_%D7%A8%D7%93%D7%95%D7%A7%D7%98%D7%90%D7%96" title="מעכבי 5-אלפא רדוקטאז – Hebrew" lang="he" hreflang="he" data-title="מעכבי 5-אלפא רדוקטאז" data-language-autonym="עברית" data-language-local-name="Hebrew" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-mk mw-list-item"><a href="https://mk.wikipedia.org/wiki/5-%D0%B0%D0%BB%D1%84%D0%B0_%D1%80%D0%B5%D0%B4%D1%83%D0%BA%D1%82%D0%B0%D0%B7%D0%B0_%D0%B8%D0%BD%D1%85%D0%B8%D0%B1%D0%B8%D1%82%D0%BE%D1%80" title="5-алфа редуктаза инхибитор – Macedonian" lang="mk" hreflang="mk" data-title="5-алфа редуктаза инхибитор" data-language-autonym="Македонски" data-language-local-name="Macedonian" class="interlanguage-link-target"><span>Македонски</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Inibidor_da_5-alfarredutase" title="Inibidor da 5-alfarredutase – Portuguese" lang="pt" hreflang="pt" data-title="Inibidor da 5-alfarredutase" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Zaviralec_testosteron-5-alfa_reduktaze" title="Zaviralec testosteron-5-alfa reduktaze – Slovenian" lang="sl" hreflang="sl" data-title="Zaviralec testosteron-5-alfa reduktaze" data-language-autonym="Slovenščina" data-language-local-name="Slovenian" class="interlanguage-link-target"><span>Slovenščina</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%86%D0%BD%D0%B3%D1%96%D0%B1%D1%96%D1%82%D0%BE%D1%80%D0%B8_5-%D0%B0%D0%BB%D1%8C%D1%84%D0%B0-%D1%80%D0%B5%D0%B4%D1%83%D0%BA%D1%82%D0%B0%D0%B7%D0%B8" title="Інгібітори 5-альфа-редуктази – Ukrainian" lang="uk" hreflang="uk" data-title="Інгібітори 5-альфа-редуктази" data-language-autonym="Українська" data-language-local-name="Ukrainian" class="interlanguage-link-target"><span>Українська</span></a></li> </ul> <div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q4639645#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/5%CE%B1-Reductase_inhibitor" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:5%CE%B1-Reductase_inhibitor" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">English</span> </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/5%CE%B1-Reductase_inhibitor"><span>Read</span></a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">Tools</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/5%CE%B1-Reductase_inhibitor"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=history"><span>View history</span></a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/5%CE%B1-Reductase_inhibitor" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/5%CE%B1-Reductase_inhibitor" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&oldid=1262650612" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&page=5%CE%B1-Reductase_inhibitor&id=1262650612&wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlQ%C4%B1sald%C4%B1c%C4%B1s%C4%B1&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2F5%25CE%25B1-Reductase_inhibitor"><span>Get shortened URL</span></a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrKodu&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2F5%25CE%25B1-Reductase_inhibitor"><span>Download QR code</span></a></li> </ul> </div> </div> <div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export" > <div class="vector-menu-heading"> Print/export </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&page=5%CE%B1-Reductase_inhibitor&action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:5-alpha-reductase_inhibitors" hreflang="en"><span>Wikimedia Commons</span></a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q4639645" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> <div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div> </div> <div id="contentSub"><div id="mw-content-subtitle"></div></div> <div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Class of medications</div> <style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background-color: #ddbbee">5α-Reductase inhibitor</th></tr><tr><td colspan="2" class="infobox-subheader"><i><a href="/wiki/Drug_class" title="Drug class">Drug class</a></i></td></tr><tr><td colspan="2" class="infobox-image"><span class="skin-invert-image" typeof="mw:File"><a href="/wiki/File:Dutasteride.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/250px-Dutasteride.svg.png" decoding="async" width="250" height="231" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/375px-Dutasteride.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/500px-Dutasteride.svg.png 2x" data-file-width="512" data-file-height="474" /></a></span><div class="infobox-caption"><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a>, one of the most widely used 5α-reductase inhibitors.</div></td></tr><tr><th colspan="2" class="infobox-header" style="background: #e8e8e8;">Class identifiers</th></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Synonym" title="Synonym">Synonyms</a></th><td class="infobox-data">Dihydrotestosterone blockers; DHT blockers</td></tr><tr><th scope="row" class="infobox-label">Use</th><td class="infobox-data"><a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">Benign prostatic hyperplasia</a>, <a href="/wiki/Pattern_hair_loss" title="Pattern hair loss">pattern hair loss</a>, <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a>, <a href="/wiki/Feminizing_hormone_therapy" title="Feminizing hormone therapy">feminizing HRT</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td class="infobox-data"><a href="/wiki/ATC_code_G04CB" class="mw-redirect" title="ATC code G04CB">G04CB</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Biological_target" title="Biological target">Biological target</a></th><td class="infobox-data"><a href="/wiki/5%CE%B1-Reductase" title="5α-Reductase">5α-Reductase</a> (<a href="/wiki/SRD5A1" title="SRD5A1">1</a>, <a href="/wiki/SRD5A2" title="SRD5A2">2</a>, <a href="/wiki/SRD5A3" title="SRD5A3">3</a>)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Chemical_classification" class="mw-redirect" title="Chemical classification">Chemical class</a></th><td class="infobox-data"><a href="/wiki/Steroid" title="Steroid">Steroids</a>; <a href="/wiki/Azasteroid" title="Azasteroid">Azasteroids</a></td></tr><tr><th colspan="2" class="infobox-header" style="background: #e8e8e8;">Legal status</th></tr><tr><td colspan="2" class="infobox-below" style="background: #e8e8e8; text-align: center"><a href="https://www.wikidata.org/wiki/Q4639645" class="extiw" title="d:Q4639645">In Wikidata</a></td></tr></tbody></table> <p><b>5α-Reductase inhibitors</b> (<b>5-ARIs</b>), also known as <b>dihydrotestosterone</b> (<b>DHT</b>) <b>blockers</b>, are a class of <a href="/wiki/Medication" title="Medication">medications</a> with <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogenic</a> effects which are used primarily in the treatment of <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">enlarged prostate</a> and <a href="/wiki/Pattern_hair_loss" title="Pattern hair loss">scalp hair loss</a>. They are also sometimes used to treat <a href="/wiki/Hirsutism" title="Hirsutism">excess hair growth</a> in women and as a component of <a href="/wiki/Feminizing_hormone_therapy" title="Feminizing hormone therapy">hormone therapy</a> for <a href="/wiki/Transgender_women" class="mw-redirect" title="Transgender women">transgender women</a>.<sup id="cite_ref-Blume-PeytaviWhiting2008_1-0" class="reference"><a href="#cite_note-Blume-PeytaviWhiting2008-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28159148_2-0" class="reference"><a href="#cite_note-pmid28159148-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> </p><p>These agents inhibit the <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> <a href="/wiki/5%CE%B1-reductase" class="mw-redirect" title="5α-reductase">5α-reductase</a>, which is involved in the <a href="/wiki/Metabolic_transformation" class="mw-redirect" title="Metabolic transformation">metabolic transformations</a> of a variety of <a href="/wiki/Endogenous" class="mw-redirect" title="Endogenous">endogenous</a> <a href="/wiki/Steroid" title="Steroid">steroids</a>. 5-ARIs are most known for preventing conversion of <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, the major <a href="/wiki/Androgen" title="Androgen">androgen</a> <a href="/wiki/Sex_hormone" title="Sex hormone">sex hormone</a>, to the more potent androgen <a href="/wiki/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT), in certain <a href="/wiki/Androgen-associated_disorder" class="mw-redirect" title="Androgen-associated disorder">androgen-associated disorders</a>. </p> <style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div> <div class="mw-heading mw-heading2"><h2 id="Medical_uses">Medical uses</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=1" title="Edit section: Medical uses"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>5-ARIs are clinically used in the treatment of conditions that are exacerbated by DHT:<sup id="cite_ref-Rossi_3-0" class="reference"><a href="#cite_note-Rossi-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> </p> <ul><li>Mild-to-moderate <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a> and <a href="/wiki/Lower_urinary_tract_symptoms" title="Lower urinary tract symptoms">lower urinary tract symptoms</a></li> <li><a href="/wiki/Pattern_hair_loss" title="Pattern hair loss">Pattern hair loss</a> in both men and women</li></ul> <p>5-ARIs can be used in the treatment of <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a> in women.<sup id="cite_ref-Blume-PeytaviWhiting2008_1-1" class="reference"><a href="#cite_note-Blume-PeytaviWhiting2008-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> The usefulness of 5-ARIs for the potential treatment of <a href="/wiki/Acne" title="Acne">acne</a> is uncertain.<sup id="cite_ref-pmid22235201_4-0" class="reference"><a href="#cite_note-pmid22235201-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> 5-ARIs are sometimes used as antiandrogens in <a href="/wiki/Feminizing_hormone_therapy" title="Feminizing hormone therapy">feminizing hormone therapy</a> for <a href="/wiki/Transgender_women" class="mw-redirect" title="Transgender women">transgender women</a> to help reduce body hair growth and scalp hair loss.<sup id="cite_ref-pmid28159148_2-1" class="reference"><a href="#cite_note-pmid28159148-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> </p><p>They have also been explored in the treatment and prevention of <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>. While the 5-ARI <a href="/wiki/Finasteride" title="Finasteride">finasteride</a> reduces the cancer risk by about a third, it also increases the fraction of aggressive forms of prostate cancer. Overall, there does not seem to be a survival benefit for prostate cancer patients under finasteride.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span class="cite-bracket">[</span>5<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Available_forms">Available forms</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=2" title="Edit section: Available forms"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a> (brand names Proscar, Propecia) inhibits the function of two of the isoenzymes (types 2 and 3) of 5α-reductase.<sup id="cite_ref-Yamana_2010_6-0" class="reference"><a href="#cite_note-Yamana_2010-6"><span class="cite-bracket">[</span>6<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span class="cite-bracket">[</span>7<span class="cite-bracket">]</span></a></sup> It decreases circulating DHT levels by up to about 70%.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a> (brand name Avodart) inhibits all three 5α-reductase isoenzymes and can decrease DHT levels by 95%.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span class="cite-bracket">[</span>9<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span class="cite-bracket">[</span>10<span class="cite-bracket">]</span></a></sup> It can also reduce DHT levels in the prostate by 97 to 99% in men with prostate cancer.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Epristeride" title="Epristeride">Epristeride</a> (brand names Aipuliete, Chuanliu) is marketed in <a href="/wiki/China" title="China">China</a> for the treatment of benign prostatic hyperplasia.<sup id="cite_ref-MortonHall1999-Epristeride_13-0" class="reference"><a href="#cite_note-MortonHall1999-Epristeride-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AdisInsight-Epristeride_14-0" class="reference"><a href="#cite_note-AdisInsight-Epristeride-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com-Epristeride_15-0" class="reference"><a href="#cite_note-Drugs.com-Epristeride-15"><span class="cite-bracket">[</span>15<span class="cite-bracket">]</span></a></sup> However, it can only decrease circulating DHT levels by about 25 to 54%.<sup id="cite_ref-Publishers1996_16-0" class="reference"><a href="#cite_note-Publishers1996-16"><span class="cite-bracket">[</span>16<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a> (brand names Ell-Cranell Alpha, Pantostin) is a topical 5-ARI used to treat pattern hair loss in <a href="/wiki/Europe" title="Europe">Europe</a>.<sup id="cite_ref-Hunnius_17-0" class="reference"><a href="#cite_note-Hunnius-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Mutschler_18-0" class="reference"><a href="#cite_note-Mutschler-18"><span class="cite-bracket">[</span>18<span class="cite-bracket">]</span></a></sup> </p> <table class="wikitable sortable mw-collapsible" style="margin-left: auto; margin-right: auto; border: none;"> <caption class="nowrap"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:5%CE%B1-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use" title="Template:5α-Reductase inhibitors marketed for clinical or veterinary use"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:5%CE%B1-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use" title="Template talk:5α-Reductase inhibitors marketed for clinical or veterinary use"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:5%CE%B1-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use" title="Special:EditPage/Template:5α-Reductase inhibitors marketed for clinical or veterinary use"><abbr title="Edit this template">e</abbr></a></li></ul></div> 5α-Reductase inhibitors marketed for clinical or veterinary use </caption> <tbody><tr> <th>Generic name</th> <th>Brand name(s)</th> <th><abbr title="5α-Reductase isoforms">Isoforms</abbr></th> <th>Route(s)</th> <th>Launch </th></tr> <tr> <td><a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></td> <td>Ell-Cranell Alpha, Pantostin</td> <td>?</td> <td>Topical</td> <td>? </td></tr> <tr> <td><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></td> <td>Avodart</td> <td>1, 2, 3</td> <td>Oral</td> <td>2001 </td></tr> <tr> <td><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></td> <td>Aipuliete, Chuanliu</td> <td>2, 3</td> <td>Oral</td> <td>2000 </td></tr> <tr> <td><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></td> <td>Proscar, Propecia</td> <td>2, 3</td> <td>Oral</td> <td>1992 </td></tr> </tbody></table> <div class="mw-heading mw-heading2"><h2 id="Side_effects">Side effects</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=3" title="Edit section: Side effects"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>5-ARIs are generally <a href="/wiki/Drug_tolerability" class="mw-redirect" title="Drug tolerability">well tolerated</a> in both men and women and produce few <a href="/wiki/Side_effect" title="Side effect">side effects</a>.<sup id="cite_ref-pmid27672412_19-0" class="reference"><a href="#cite_note-pmid27672412-19"><span class="cite-bracket">[</span>19<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27784557_20-0" class="reference"><a href="#cite_note-pmid27784557-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup> However, they have been found to have some risks in studies with men, including slightly increased risks of decreased <a href="/wiki/Libido" title="Libido">libido</a>, <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>, <a href="/wiki/Ejaculatory_dysfunction_(disambiguation)" class="mw-redirect mw-disambig" title="Ejaculatory dysfunction (disambiguation)">ejaculatory dysfunction</a>, <a href="/wiki/Infertility" title="Infertility">infertility</a>, <a href="/wiki/Breast_tenderness" class="mw-redirect" title="Breast tenderness">breast tenderness</a>, <a href="/wiki/Gynecomastia" title="Gynecomastia">gynecomastia</a>, <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a>, <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>, <a href="/wiki/Self-harm" title="Self-harm">self-harm</a>, and <a href="/wiki/Dementia" title="Dementia">dementia</a>.<sup id="cite_ref-pmid27784557_20-1" class="reference"><a href="#cite_note-pmid27784557-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28319231_21-0" class="reference"><a href="#cite_note-pmid28319231-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-WelkMcArthur2017_22-0" class="reference"><a href="#cite_note-WelkMcArthur2017-22"><span class="cite-bracket">[</span>22<span class="cite-bracket">]</span></a></sup> In addition, although 5-ARIs decrease the overall risk of developing <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>, they have been found to increase the risk of developing certain rare but high-grade forms of prostate cancer.<sup id="cite_ref-pmid27672412_19-1" class="reference"><a href="#cite_note-pmid27672412-19"><span class="cite-bracket">[</span>19<span class="cite-bracket">]</span></a></sup> As a result, the FDA has notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-ARI class of drugs has been revised to include new safety information about the increased risk of being diagnosed with these rare but more serious forms of prostate cancer.<sup id="cite_ref-Drugs.com-Label_23-0" class="reference"><a href="#cite_note-Drugs.com-Label-23"><span class="cite-bracket">[</span>23<span class="cite-bracket">]</span></a></sup> Finasteride has also been associated with <a href="/wiki/Intraoperative_floppy_iris_syndrome" title="Intraoperative floppy iris syndrome">intraoperative floppy iris syndrome</a> and <a href="/wiki/Cataract" title="Cataract">cataract</a> formation.<sup id="cite_ref-pmid21555201_24-0" class="reference"><a href="#cite_note-pmid21555201-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18053919_25-0" class="reference"><a href="#cite_note-pmid18053919-25"><span class="cite-bracket">[</span>25<span class="cite-bracket">]</span></a></sup> Depressive symptoms and suicidality have been reported.<sup id="cite_ref-pmid28456011_26-0" class="reference"><a href="#cite_note-pmid28456011-26"><span class="cite-bracket">[</span>26<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Sexual_dysfunction">Sexual dysfunction</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=4" title="Edit section: Sexual dysfunction"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">Sexual dysfunction</a>, including <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>, <a href="/wiki/Loss_of_libido" class="mw-redirect" title="Loss of libido">loss of libido</a>, and <a href="/wiki/Hypospermia" title="Hypospermia">reduced ejaculate</a>, may occur in 3.4 to 15.8% of men treated with finasteride or dutasteride.<sup id="cite_ref-pmid27672412_19-2" class="reference"><a href="#cite_note-pmid27672412-19"><span class="cite-bracket">[</span>19<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27475241_27-0" class="reference"><a href="#cite_note-pmid27475241-27"><span class="cite-bracket">[</span>27<span class="cite-bracket">]</span></a></sup> This is linked to lower <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> and can cause stress in relationships.<sup id="cite_ref-Gur2013_28-0" class="reference"><a href="#cite_note-Gur2013-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup> There is also an association with lowered sexual desire.<sup id="cite_ref-Tra2011_29-0" class="reference"><a href="#cite_note-Tra2011-29"><span class="cite-bracket">[</span>29<span class="cite-bracket">]</span></a></sup> It has been reported that in a subset of men, these adverse sexual side effects may persist even after discontinuation of finasteride or dutasteride.<sup id="cite_ref-Tra2011_29-1" class="reference"><a href="#cite_note-Tra2011-29"><span class="cite-bracket">[</span>29<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Breast_changes">Breast changes</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=5" title="Edit section: Breast changes"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>5-ARIs have a small risk of <a href="/wiki/Breast" title="Breast">breast</a> changes in men including <a href="/wiki/Breast_tenderness" class="mw-redirect" title="Breast tenderness">breast tenderness</a> and <a href="/wiki/Gynecomastia" title="Gynecomastia">gynecomastia</a> (breast development/enlargement).<sup id="cite_ref-pmid27784557_20-2" class="reference"><a href="#cite_note-pmid27784557-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup> The risk of gynecomastia is about 1.3%.<sup id="cite_ref-pmid27784557_20-3" class="reference"><a href="#cite_note-pmid27784557-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup> There is no association of 5-ARIs with <a href="/wiki/Male_breast_cancer" title="Male breast cancer">male breast cancer</a>.<sup id="cite_ref-pmid27784557_20-4" class="reference"><a href="#cite_note-pmid27784557-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid29697934_30-0" class="reference"><a href="#cite_note-pmid29697934-30"><span class="cite-bracket">[</span>30<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Emotional_changes">Emotional changes</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=6" title="Edit section: Emotional changes"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>A 2017 <a href="/wiki/Population_study" title="Population study">population-based</a>, <a href="/wiki/Matching_(statistics)" title="Matching (statistics)">matched</a>-<a href="/wiki/Cohort_study" title="Cohort study">cohort study</a> of 93,197 men aged 66 years and older with BPH found that finasteride and dutasteride were associated with a significantly increased risk of depression (<a href="/wiki/Hazard_ratio" title="Hazard ratio"><abbr title="Hazard ratio">HR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Hazard ratio</span>, 1.94; 95% <a href="/wiki/Confidence_interval" title="Confidence interval"><abbr title="Confidence interval">CI</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Confidence interval</span>, 1.73–2.16) and <a href="/wiki/Self-harm" title="Self-harm">self-harm</a> (HR, 1.88; 95% CI, 1.34–2.64) during the first 18 months of treatment, but were not associated with an increased risk of <a href="/wiki/Suicide" title="Suicide">suicide</a> (HR, 0.88; 95% CI, 0.53–1.45).<sup id="cite_ref-pmid29528971_31-0" class="reference"><a href="#cite_note-pmid29528971-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Traish2018_32-0" class="reference"><a href="#cite_note-Traish2018-32"><span class="cite-bracket">[</span>32<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid30651009_33-0" class="reference"><a href="#cite_note-pmid30651009-33"><span class="cite-bracket">[</span>33<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28319231_21-1" class="reference"><a href="#cite_note-pmid28319231-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup> After the initial 18 months of therapy, the risk of self-harm was no longer heightened, whereas the elevation in risk of depression lessened but remained marginally increased (HR, 1.22; 95% CI, 1.08–1.37).<sup id="cite_ref-pmid29528971_31-1" class="reference"><a href="#cite_note-pmid29528971-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Traish2018_32-1" class="reference"><a href="#cite_note-Traish2018-32"><span class="cite-bracket">[</span>32<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28319231_21-2" class="reference"><a href="#cite_note-pmid28319231-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup> The absolute increase in the rate of depression was 247 per 100,000 patient-years and of self-harm was 17 per 100,000 patient-years.<sup id="cite_ref-pmid28319231_21-3" class="reference"><a href="#cite_note-pmid28319231-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28319227_34-0" class="reference"><a href="#cite_note-pmid28319227-34"><span class="cite-bracket">[</span>34<span class="cite-bracket">]</span></a></sup> As such, on the basis of these findings, it has been stated that cases of depression in patients that are attributable to 5-ARIs will be encountered on occasion, while cases of self-harm attributable to 5-ARIs will be encountered very rarely.<sup id="cite_ref-pmid28319227_34-1" class="reference"><a href="#cite_note-pmid28319227-34"><span class="cite-bracket">[</span>34<span class="cite-bracket">]</span></a></sup> There were no differences in the rates of depression, self-harm, and suicide between finasteride and dutasteride, suggesting that the specific 5-ARI used does not influence the risks.<sup id="cite_ref-pmid30651009_33-1" class="reference"><a href="#cite_note-pmid30651009-33"><span class="cite-bracket">[</span>33<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28319231_21-4" class="reference"><a href="#cite_note-pmid28319231-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28319227_34-2" class="reference"><a href="#cite_note-pmid28319227-34"><span class="cite-bracket">[</span>34<span class="cite-bracket">]</span></a></sup> The absolute risks of self-harm and depression with 5-ARIs remain low (0.14% and 2.0%, respectively).<sup id="cite_ref-pmid29449167_35-0" class="reference"><a href="#cite_note-pmid29449167-35"><span class="cite-bracket">[</span>35<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Pharmacology">Pharmacology</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=7" title="Edit section: Pharmacology"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The pharmacology of 5α-reductase inhibition is complex, but involves the binding of <a href="/wiki/NADPH" class="mw-redirect" title="NADPH">NADPH</a> to the enzyme followed by the substrate. Specific substrates include <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, <a href="/wiki/Progesterone" title="Progesterone">progesterone</a>, <a href="/wiki/Androstenedione" title="Androstenedione">androstenedione</a>, <a href="/wiki/Epitestosterone" title="Epitestosterone">epitestosterone</a>, <a href="/wiki/Cortisol" title="Cortisol">cortisol</a>, <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>, and <a href="/wiki/Deoxycorticosterone" title="Deoxycorticosterone">deoxycorticosterone</a>. The entire physiologic effect of their reduction is unknown, but likely related to their excretion or is itself physiologic.<sup id="cite_ref-pmid22235201_4-1" class="reference"><a href="#cite_note-pmid22235201-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> 5α-Reductase reduces the steroid Δ<sup>4,5</sup> double bond in testosterone to its more active form DHT. Thus, inhibition results in decreased amounts of DHT. Because of this, slight elevations in testosterone and estradiol levels occur.<sup id="cite_ref-:1_36-0" class="reference"><a href="#cite_note-:1-36"><span class="cite-bracket">[</span>36<span class="cite-bracket">]</span></a></sup> The 5α-reductase reaction is a rate-limiting step in the testosterone reduction and involves the binding of <a href="/wiki/NADPH" class="mw-redirect" title="NADPH">NADPH</a> to the enzyme followed by the substrate.<sup id="cite_ref-pmid22235201_4-2" class="reference"><a href="#cite_note-pmid22235201-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid16834758_37-0" class="reference"><a href="#cite_note-pmid16834758-37"><span class="cite-bracket">[</span>37<span class="cite-bracket">]</span></a></sup> </p> <dl><dd><dl><dd><dl><dd><i>Substrate + NADPH + H<sup>+</sup> → 5α-substrate + NADP<sup>+</sup></i></dd></dl></dd></dl></dd></dl> <p>Beyond being a catalyst in the <a href="/wiki/Rate-limiting_step" class="mw-redirect" title="Rate-limiting step">rate-limiting step</a> in testosterone reduction, 5α-reductase isoforms I and II reduce progesterone to <a href="/wiki/5%CE%B1-dihydroprogesterone" class="mw-redirect" title="5α-dihydroprogesterone">5α-dihydroprogesterone</a> (5α-DHP) and deoxycorticosterone to <a href="/wiki/Dihydrodeoxycorticosterone" title="Dihydrodeoxycorticosterone">dihydrodeoxycorticosterone</a> (DHDOC). In vitro and animal models suggest subsequent 3α-reduction of DHT, 5α-DHP and DHDOC lead to neurosteroid metabolites with effect on cerebral function. These <a href="/wiki/Neurosteroid" title="Neurosteroid">neurosteroids</a>, which include <a href="/wiki/Allopregnanolone" title="Allopregnanolone">allopregnanolone</a>, <a href="/wiki/Tetrahydrodeoxycorticosterone" title="Tetrahydrodeoxycorticosterone">tetrahydrodeoxycorticosterone</a> (THDOC), and <a href="/wiki/3%CE%B1-androstanediol" class="mw-redirect" title="3α-androstanediol">3α-androstanediol</a>, act as potent <a href="/wiki/Positive_allosteric_modulator" class="mw-redirect" title="Positive allosteric modulator">positive allosteric modulators</a> of <a href="/wiki/GABAA_receptor" title="GABAA receptor">GABA<sub>A</sub> receptors</a>, and have <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a>, <a href="/wiki/Anxiolytic" title="Anxiolytic">anxiolytic</a>, <a href="/wiki/Aphrodisiac" title="Aphrodisiac">prosexual</a>, and <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a> effects.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span class="cite-bracket">[</span>38<span class="cite-bracket">]</span></a></sup> <a href="/wiki/5%CE%B1-Dihydrocortisol" title="5α-Dihydrocortisol">5α-Dihydrocortisol</a> is present in the <a href="/wiki/Aqueous_humor" class="mw-redirect" title="Aqueous humor">aqueous humor</a> of the eye, is synthesized in the <a href="/wiki/Lens_(anatomy)" class="mw-redirect" title="Lens (anatomy)">lens</a>, and might help make the aqueous humor itself.<sup id="cite_ref-Cort_39-0" class="reference"><a href="#cite_note-Cort-39"><span class="cite-bracket">[</span>39<span class="cite-bracket">]</span></a></sup> <a href="/wiki/5%CE%B1-Dihydroaldosterone" title="5α-Dihydroaldosterone">5α-Dihydroaldosterone</a> is a potent <a href="/wiki/Antidiuretic" title="Antidiuretic">antinatriuretic</a> agent, although different from <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>. Its formation in the kidney is enhanced by restriction of dietary salt, suggesting it may help retain sodium.<sup id="cite_ref-Kenyon_1983_40-0" class="reference"><a href="#cite_note-Kenyon_1983-40"><span class="cite-bracket">[</span>40<span class="cite-bracket">]</span></a></sup> 5α-DHP is a major hormone in circulation of normal cycling and pregnant women.<sup id="cite_ref-pmid914969_41-0" class="reference"><a href="#cite_note-pmid914969-41"><span class="cite-bracket">[</span>41<span class="cite-bracket">]</span></a></sup> </p><p>Other enzymes compensate to a degree for the absent conversion of 5α-reductase, specifically with local expression at the skin of reductive <a href="/wiki/17%CE%B2-hydroxysteroid_dehydrogenase" class="mw-redirect" title="17β-hydroxysteroid dehydrogenase">17β-hydroxysteroid dehydrogenase</a>, and oxidative <a href="/wiki/3%CE%B1-hydroxysteroid_dehydrogenase" class="mw-redirect" title="3α-hydroxysteroid dehydrogenase">3α-hydroxysteroid dehydrogenase</a> and <a href="/wiki/3%CE%B2-hydroxysteroid_dehydrogenase" class="mw-redirect" title="3β-hydroxysteroid dehydrogenase">3β-hydroxysteroid dehydrogenase</a> enzymes.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span class="cite-bracket">[</span>42<span class="cite-bracket">]</span></a></sup> </p><p>In BPH, DHT acts as a potent cellular androgen and promotes <a href="/wiki/Prostate" title="Prostate">prostate</a> growth; therefore, DHT blockers inhibit and alleviate symptoms of BPH. In alopecia, male and female-pattern baldness is an effect of androgenic receptor activation, so reducing levels of DHT also reduces hair loss. </p> <div class="mw-heading mw-heading2"><h2 id="History">History</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=8" title="Edit section: History"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Finasteride was the first 5-ARI to be introduced for medical use.<sup id="cite_ref-BurgerAbraham2003_43-0" class="reference"><a href="#cite_note-BurgerAbraham2003-43"><span class="cite-bracket">[</span>43<span class="cite-bracket">]</span></a></sup> It was marketed for the treatment of BPH in 1992 and was subsequently approved for the treatment of pattern hair loss in 1997.<sup id="cite_ref-BurgerAbraham2003_43-1" class="reference"><a href="#cite_note-BurgerAbraham2003-43"><span class="cite-bracket">[</span>43<span class="cite-bracket">]</span></a></sup> Epristeride was the second 5-ARI to be introduced and was marketed for the treatment of BPH in <a href="/wiki/China" title="China">China</a> in 2000.<sup id="cite_ref-AdisInsight-Epristeride_14-1" class="reference"><a href="#cite_note-AdisInsight-Epristeride-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup> Dutasteride was approved for the treatment of BPH in 2001 and was subsequently approved for pattern hair loss in <a href="/wiki/South_Korea" title="South Korea">South Korea</a> in 2009 and in <a href="/wiki/Japan" title="Japan">Japan</a> in 2015.<sup id="cite_ref-Llewellyn2011_44-0" class="reference"><a href="#cite_note-Llewellyn2011-44"><span class="cite-bracket">[</span>44<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-MacDonald_45-0" class="reference"><a href="#cite_note-MacDonald-45"><span class="cite-bracket">[</span>45<span class="cite-bracket">]</span></a></sup> The <a href="/wiki/Patent_protection" class="mw-redirect" title="Patent protection">patent protection</a> on finasteride and dutasteride has expired and both drugs are available as <a href="/wiki/Generic_drug" title="Generic drug">generic medications</a>.<sup id="cite_ref-SataloffSclafani2015_46-0" class="reference"><a href="#cite_note-SataloffSclafani2015-46"><span class="cite-bracket">[</span>46<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com-Dutasteride_47-0" class="reference"><a href="#cite_note-Drugs.com-Dutasteride-47"><span class="cite-bracket">[</span>47<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Research">Research</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=9" title="Edit section: Research"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>5-ARIs have been studied in combination with the <a href="/wiki/Nonsteroidal_antiandrogen" title="Nonsteroidal antiandrogen">nonsteroidal antiandrogen</a> <a href="/wiki/Bicalutamide" title="Bicalutamide">bicalutamide</a> for the treatment of prostate cancer.<sup id="cite_ref-pmid15138573_48-0" class="reference"><a href="#cite_note-pmid15138573-48"><span class="cite-bracket">[</span>48<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid15151957_49-0" class="reference"><a href="#cite_note-pmid15151957-49"><span class="cite-bracket">[</span>49<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid16844453_50-0" class="reference"><a href="#cite_note-pmid16844453-50"><span class="cite-bracket">[</span>50<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19796455_51-0" class="reference"><a href="#cite_note-pmid19796455-51"><span class="cite-bracket">[</span>51<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26048455_52-0" class="reference"><a href="#cite_note-pmid26048455-52"><span class="cite-bracket">[</span>52<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26702991_53-0" class="reference"><a href="#cite_note-pmid26702991-53"><span class="cite-bracket">[</span>53<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27330919_54-0" class="reference"><a href="#cite_note-pmid27330919-54"><span class="cite-bracket">[</span>54<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="See_also">See also</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=10" title="Edit section: See also"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <ul><li><a href="/wiki/List_of_5%CE%B1-reductase_inhibitors" title="List of 5α-reductase inhibitors">List of 5α-reductase inhibitors</a></li> <li><a href="/wiki/Discovery_and_development_of_5%CE%B1-reductase_inhibitors" title="Discovery and development of 5α-reductase inhibitors">Discovery and development of 5α-reductase inhibitors</a></li> <li><a href="/wiki/CYP17A1_inhibitor" title="CYP17A1 inhibitor">CYP17A1 inhibitor</a></li> <li><a href="/wiki/Neurosteroidogenesis_inhibitor" title="Neurosteroidogenesis inhibitor">Neurosteroidogenesis inhibitor</a></li></ul> <div class="mw-heading mw-heading2"><h2 id="References">References</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&section=11" title="Edit section: References"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-columns references-column-width" style="column-width: 30em;"> <ol class="references"> <li id="cite_note-Blume-PeytaviWhiting2008-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Blume-PeytaviWhiting2008_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Blume-PeytaviWhiting2008_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite id="CITEREFUlrike_Blume-PeytaviDavid_A._WhitingRalph_M._Trüeb2008" class="citation book cs1">Ulrike Blume-Peytavi; David A. Whiting; Ralph M. Trüeb (26 June 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=pHrX2-huQCoC&pg=PA368"><i>Hair Growth and Disorders</i></a>. Springer Science & Business Media. pp. 368–370. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-540-46911-7" title="Special:BookSources/978-3-540-46911-7"><bdi>978-3-540-46911-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20231109232624/https://books.google.com/books?id=pHrX2-huQCoC&pg=PA368#v=onepage&q&f=false">Archived</a> from the original on 9 November 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">29 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Hair+Growth+and+Disorders&rft.pages=368-370&rft.pub=Springer+Science+%26+Business+Media&rft.date=2008-06-26&rft.isbn=978-3-540-46911-7&rft.au=Ulrike+Blume-Peytavi&rft.au=David+A.+Whiting&rft.au=Ralph+M.+Tr%C3%BCeb&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DpHrX2-huQCoC%26pg%3DPA368&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid28159148-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28159148_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28159148_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWespDeutsch2017" class="citation journal cs1">Wesp LM, Deutsch MB (2017). "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". <i>Psychiatr. Clin. North Am</i>. <b>40</b> (1): 99–111. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.psc.2016.10.006">10.1016/j.psc.2016.10.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28159148">28159148</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Psychiatr.+Clin.+North+Am.&rft.atitle=Hormonal+and+Surgical+Treatment+Options+for+Transgender+Women+and+Transfeminine+Spectrum+Persons&rft.volume=40&rft.issue=1&rft.pages=99-111&rft.date=2017&rft_id=info%3Adoi%2F10.1016%2Fj.psc.2016.10.006&rft_id=info%3Apmid%2F28159148&rft.aulast=Wesp&rft.aufirst=LM&rft.au=Deutsch%2C+MB&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Rossi-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rossi_3-0">^</a></b></span> <span class="reference-text">Rossi S (Ed.) (2004). <i><a href="/wiki/Australian_Medicines_Handbook" title="Australian Medicines Handbook">Australian Medicines Handbook</a> 2004</i>. Adelaide: Australian Medicines Handbook. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/0-9578521-4-2" title="Special:BookSources/0-9578521-4-2">0-9578521-4-2</a></span> </li> <li id="cite_note-pmid22235201-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22235201_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22235201_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22235201_4-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAzzouniGodoyLiMohler2012" class="citation journal cs1">Azzouni F, Godoy A, Li Y, Mohler J, et al. (2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436">"The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases"</a>. <i>Adv. Urol</i>. <b>2012</b>: 530121. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2012%2F530121">10.1155/2012/530121</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253436">3253436</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22235201">22235201</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Adv.+Urol.&rft.atitle=The+5+alpha-reductase+isozyme+family%3A+a+review+of+basic+biology+and+their+role+in+human+diseases&rft.volume=2012&rft.pages=530121&rft.date=2012&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3253436%23id-name%3DPMC&rft_id=info%3Apmid%2F22235201&rft_id=info%3Adoi%2F10.1155%2F2012%2F530121&rft.aulast=Azzouni&rft.aufirst=F&rft.au=Godoy%2C+A&rft.au=Li%2C+Y&rft.au=Mohler%2C+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3253436&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFThompsonGoodmanTangenParnes2013" class="citation journal cs1">Thompson, Ian M. Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G. (2013-08-15). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141537">"Long-Term Survival of Participants in the Prostate Cancer Prevention Trial"</a>. <i>New England Journal of Medicine</i>. <b>369</b> (7): 603–610. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1215932">10.1056/NEJMoa1215932</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0028-4793">0028-4793</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141537">4141537</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23944298">23944298</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=New+England+Journal+of+Medicine&rft.atitle=Long-Term+Survival+of+Participants+in+the+Prostate+Cancer+Prevention+Trial&rft.volume=369&rft.issue=7&rft.pages=603-610&rft.date=2013-08-15&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4141537%23id-name%3DPMC&rft.issn=0028-4793&rft_id=info%3Apmid%2F23944298&rft_id=info%3Adoi%2F10.1056%2FNEJMoa1215932&rft.aulast=Thompson&rft.aufirst=Ian+M.+Jr.&rft.au=Goodman%2C+Phyllis+J.&rft.au=Tangen%2C+Catherine+M.&rft.au=Parnes%2C+Howard+L.&rft.au=Minasian%2C+Lori+M.&rft.au=Godley%2C+Paul+A.&rft.au=Lucia%2C+M.+Scott&rft.au=Ford%2C+Leslie+G.&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4141537&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Yamana_2010-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Yamana_2010_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYamanaLabrieLuu-The2010" class="citation journal cs1">Yamana K, Labrie F, Luu-The V (January 2010). "Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". <i>Hormone Molecular Biology and Clinical Investigation</i>. <b>2</b> (3): 293–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1515%2Fhmbci.2010.035">10.1515/hmbci.2010.035</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25961201">25961201</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28841145">28841145</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hormone+Molecular+Biology+and+Clinical+Investigation&rft.atitle=Human+type+3+5%CE%B1-reductase+is+expressed+in+peripheral+tissues+at+higher+levels+than+types+1+and+2+and+its+activity+is+potently+inhibited+by+finasteride+and+dutasteride&rft.volume=2&rft.issue=3&rft.pages=293-9&rft.date=2010-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28841145%23id-name%3DS2CID&rft_id=info%3Apmid%2F25961201&rft_id=info%3Adoi%2F10.1515%2Fhmbci.2010.035&rft.aulast=Yamana&rft.aufirst=K&rft.au=Labrie%2C+F&rft.au=Luu-The%2C+V&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYamana_K.Labrie_F.Luu-The_V.2010" class="citation journal cs1">Yamana K.; Labrie F.; Luu-The V.; et al. (2010). "Human type 3 5α- reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited finasteride and dutasteride". <i>Hormone Molecular Biology and Clinical Investigation</i>. <b>2</b> (3): 293–299. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1515%2Fhmbci.2010.035">10.1515/hmbci.2010.035</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25961201">25961201</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28841145">28841145</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hormone+Molecular+Biology+and+Clinical+Investigation&rft.atitle=Human+type+3+5%CE%B1-+reductase+is+expressed+in+peripheral+tissues+at+higher+levels+than+types+1+and+2+and+its+activity+is+potently+inhibited+finasteride+and+dutasteride&rft.volume=2&rft.issue=3&rft.pages=293-299&rft.date=2010&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28841145%23id-name%3DS2CID&rft_id=info%3Apmid%2F25961201&rft_id=info%3Adoi%2F10.1515%2Fhmbci.2010.035&rft.au=Yamana+K.&rft.au=Labrie+F.&rft.au=Luu-The+V.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMcConnell_J._D.Wilson_J._D.George_F._W.Geller_J.1992" class="citation journal cs1">McConnell J. D.; Wilson J. D.; George F. W.; Geller J.; Pappas F.; Stoner E. (1992). "Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia". <i>Journal of Clinical Endocrinology and Metabolism</i>. <b>74</b> (3): 505–508. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem.74.3.1371291">10.1210/jcem.74.3.1371291</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1371291">1371291</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Finasteride%2C+an+inhibitor+of+5%CE%B1-reductase%2C+suppresses+prostatic+dihydrotestosterone+in+men+with+benign+prostatic+hyperplasia&rft.volume=74&rft.issue=3&rft.pages=505-508&rft.date=1992&rft_id=info%3Adoi%2F10.1210%2Fjcem.74.3.1371291&rft_id=info%3Apmid%2F1371291&rft.au=McConnell+J.+D.&rft.au=Wilson+J.+D.&rft.au=George+F.+W.&rft.au=Geller+J.&rft.au=Pappas+F.&rft.au=Stoner+E.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFClark_R._V.Hermann_D._J.Cunningham_G._R.Wilson_T._H.2004" class="citation journal cs1">Clark R. V.; Hermann D. J.; Cunningham G. R.; Wilson T. H.; Morrill B. B.; Hobbs S. (2004). "Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor". <i>Journal of Clinical Endocrinology and Metabolism</i>. <b>89</b> (5): 2179–2184. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2003-030330">10.1210/jc.2003-030330</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15126539">15126539</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Marked+suppression+of+dihydrotestosterone+in+men+with+benign+prostatic+hyperplasia+by+dutasteride%2C+a+dual+5%CE%B1-reductase+inhibitor&rft.volume=89&rft.issue=5&rft.pages=2179-2184&rft.date=2004&rft_id=info%3Adoi%2F10.1210%2Fjc.2003-030330&rft_id=info%3Apmid%2F15126539&rft.au=Clark+R.+V.&rft.au=Hermann+D.+J.&rft.au=Cunningham+G.+R.&rft.au=Wilson+T.+H.&rft.au=Morrill+B.+B.&rft.au=Hobbs+S.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMoss_G._P.1989" class="citation journal cs1">Moss G. P. (1989). <a rel="nofollow" class="external text" href="https://doi.org/10.1351%2Fpac198961101783">"Nomenclature of steroids (Recommendations 1989)"</a>. <i>Pure and Applied Chemistry</i>. <b>61</b> (10): 1783–1822. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1351%2Fpac198961101783">10.1351/pac198961101783</a></span>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:97612891">97612891</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pure+and+Applied+Chemistry&rft.atitle=Nomenclature+of+steroids+%28Recommendations+1989%29&rft.volume=61&rft.issue=10&rft.pages=1783-1822&rft.date=1989&rft_id=info%3Adoi%2F10.1351%2Fpac198961101783&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A97612891%23id-name%3DS2CID&rft.au=Moss+G.+P.&rft_id=https%3A%2F%2Fdoi.org%2F10.1351%252Fpac198961101783&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text">G. L. Andriole, P. Humphrey, P. Ray et al., "Effect of the dual 5α-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer,"</span> </li> <li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGleave_M.Qian_J.Andreou_C.2006" class="citation journal cs1">Gleave M.; Qian J.; Andreou C.; et al. (2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fpros.20499">"The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study"</a>. <i>The Prostate</i>. <b>66</b> (15): 1674–1685. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fpros.20499">10.1002/pros.20499</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16927304">16927304</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:40446842">40446842</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Prostate&rft.atitle=The+effects+of+the+dual+5%CE%B1-reductase+inhibitor+dutasteride+on+localized+prostate+cancer%E2%80%94results+from+a+4-month+pre-radical+prostatectomy+study&rft.volume=66&rft.issue=15&rft.pages=1674-1685&rft.date=2006&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40446842%23id-name%3DS2CID&rft_id=info%3Apmid%2F16927304&rft_id=info%3Adoi%2F10.1002%2Fpros.20499&rft.au=Gleave+M.&rft.au=Qian+J.&rft.au=Andreou+C.&rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fpros.20499&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-MortonHall1999-Epristeride-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-MortonHall1999-Epristeride_13-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFI.K._MortonJudith_M._Hall1999" class="citation book cs1">I.K. Morton; Judith M. Hall (31 October 1999). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=mqaOMOtk61IC&pg=PA113"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science & Business Media. pp. 113–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7514-0499-9" title="Special:BookSources/978-0-7514-0499-9"><bdi>978-0-7514-0499-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240224185652/https://books.google.com/books?id=mqaOMOtk61IC&pg=PA113#v=onepage&q&f=false">Archived</a> from the original on 24 February 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">4 June</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Concise+Dictionary+of+Pharmacological+Agents%3A+Properties+and+Synonyms&rft.pages=113-&rft.pub=Springer+Science+%26+Business+Media&rft.date=1999-10-31&rft.isbn=978-0-7514-0499-9&rft.au=I.K.+Morton&rft.au=Judith+M.+Hall&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DmqaOMOtk61IC%26pg%3DPA113&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-AdisInsight-Epristeride-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-AdisInsight-Epristeride_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AdisInsight-Epristeride_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://adisinsight.springer.com/drugs/800002533">"Epristeride - AdisInsight"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161108135117/http://adisinsight.springer.com/drugs/800002533">Archived</a> from the original on 2016-11-08<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-06-04</span></span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Epristeride+-+AdisInsight&rft_id=http%3A%2F%2Fadisinsight.springer.com%2Fdrugs%2F800002533&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Drugs.com-Epristeride-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-Drugs.com-Epristeride_15-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/international/epristeride.html">"List of 21 Benign Prostatic Hyperplasia Medications Compared"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20171211105106/https://www.drugs.com/international/epristeride.html">Archived</a> from the original on 2017-12-11<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-06-04</span></span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=List+of+21+Benign+Prostatic+Hyperplasia+Medications+Compared&rft_id=https%3A%2F%2Fwww.drugs.com%2Finternational%2Fepristeride.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Publishers1996-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-Publishers1996_16-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBentham_Science_Publishers1996" class="citation book cs1">Bentham Science Publishers (February 1996). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=IYn4Va7wtAoC&pg=PA70"><i>Current Pharmaceutical Design</i></a>. Bentham Science Publishers. pp. 70–.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Current+Pharmaceutical+Design&rft.pages=70-&rft.pub=Bentham+Science+Publishers&rft.date=1996-02&rft.au=Bentham+Science+Publishers&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DIYn4Va7wtAoC%26pg%3DPA70&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Hunnius-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hunnius_17-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBergerWachter1998" class="citation book cs1 cs1-prop-foreign-lang-source">Berger, Artur; Wachter, Helmut, eds. (1998). <i>Hunnius Pharmazeutisches Wörterbuch</i> (in German) (8th ed.). Walter de Gruyter Verlag. p. 486. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-11-015793-2" title="Special:BookSources/978-3-11-015793-2"><bdi>978-3-11-015793-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Hunnius+Pharmazeutisches+W%C3%B6rterbuch&rft.pages=486&rft.edition=8th&rft.pub=Walter+de+Gruyter+Verlag&rft.date=1998&rft.isbn=978-3-11-015793-2&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Mutschler-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mutschler_18-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMutschlerGerd_GeisslingerHeyo_K._KroemerMonika_Schäfer-Korting2001" class="citation book cs1 cs1-prop-foreign-lang-source">Mutschler, Ernst; Gerd Geisslinger; Heyo K. Kroemer; Monika Schäfer-Korting (2001). <i>Arzneimittelwirkungen</i> (in German) (8th ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. p. 453. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-8047-1763-3" title="Special:BookSources/978-3-8047-1763-3"><bdi>978-3-8047-1763-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Arzneimittelwirkungen&rft.place=Stuttgart&rft.pages=453&rft.edition=8th&rft.pub=Wissenschaftliche+Verlagsgesellschaft&rft.date=2001&rft.isbn=978-3-8047-1763-3&rft.aulast=Mutschler&rft.aufirst=Ernst&rft.au=Gerd+Geisslinger&rft.au=Heyo+K.+Kroemer&rft.au=Monika+Sch%C3%A4fer-Korting&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid27672412-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid27672412_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid27672412_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid27672412_19-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHirshburgKelseyTherrienGavino2016" class="citation journal cs1">Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS (2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004">"Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review"</a>. <i>J Clin Aesthet Dermatol</i>. <b>9</b> (7): 56–62. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023004">5023004</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27672412">27672412</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=J+Clin+Aesthet+Dermatol&rft.atitle=Adverse+Effects+and+Safety+of+5-alpha+Reductase+Inhibitors+%28Finasteride%2C+Dutasteride%29%3A+A+Systematic+Review&rft.volume=9&rft.issue=7&rft.pages=56-62&rft.date=2016&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5023004%23id-name%3DPMC&rft_id=info%3Apmid%2F27672412&rft.aulast=Hirshburg&rft.aufirst=JM&rft.au=Kelsey%2C+PA&rft.au=Therrien%2C+CA&rft.au=Gavino%2C+AC&rft.au=Reichenberg%2C+JS&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5023004&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid27784557-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid27784557_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid27784557_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid27784557_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid27784557_20-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid27784557_20-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTrostSaitzHellstrom2013" class="citation journal cs1">Trost L, Saitz TR, Hellstrom WJ (2013). "Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review". <i>Sex Med Rev</i>. <b>1</b> (1): 24–41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fsmrj.3">10.1002/smrj.3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27784557">27784557</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Sex+Med+Rev&rft.atitle=Side+Effects+of+5-Alpha+Reductase+Inhibitors%3A+A+Comprehensive+Review&rft.volume=1&rft.issue=1&rft.pages=24-41&rft.date=2013&rft_id=info%3Adoi%2F10.1002%2Fsmrj.3&rft_id=info%3Apmid%2F27784557&rft.aulast=Trost&rft.aufirst=L&rft.au=Saitz%2C+TR&rft.au=Hellstrom%2C+WJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid28319231-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28319231_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28319231_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid28319231_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid28319231_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid28319231_21-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWelkMcArthurOrdonAnderson2017" class="citation journal cs1">Welk B, McArthur E, Ordon M, Anderson KK, Hayward J, Dixon S (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818776">"Association of Suicidality and Depression With 5α-Reductase Inhibitors"</a>. <i>JAMA Intern Med</i>. <b>177</b> (5): 683–691. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamainternmed.2017.0089">10.1001/jamainternmed.2017.0089</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818776">5818776</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28319231">28319231</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA+Intern+Med&rft.atitle=Association+of+Suicidality+and+Depression+With+5%CE%B1-Reductase+Inhibitors&rft.volume=177&rft.issue=5&rft.pages=683-691&rft.date=2017&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5818776%23id-name%3DPMC&rft_id=info%3Apmid%2F28319231&rft_id=info%3Adoi%2F10.1001%2Fjamainternmed.2017.0089&rft.aulast=Welk&rft.aufirst=B&rft.au=McArthur%2C+E&rft.au=Ordon%2C+M&rft.au=Anderson%2C+KK&rft.au=Hayward%2C+J&rft.au=Dixon%2C+S&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5818776&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-WelkMcArthur2017-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-WelkMcArthur2017_22-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWelkMcArthurOrdonMorrow2017" class="citation journal cs1">Welk, Blayne; McArthur, Eric; Ordon, Michael; Morrow, Sarah A.; Hayward, Jade; Dixon, Stephanie (2017). "The risk of dementia with the use of 5 alpha reductase inhibitors". <i>Journal of the Neurological Sciences</i>. <b>379</b>: 109–111. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jns.2017.05.064">10.1016/j.jns.2017.05.064</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0022-510X">0022-510X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28716218">28716218</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4765640">4765640</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+Neurological+Sciences&rft.atitle=The+risk+of+dementia+with+the+use+of+5+alpha+reductase+inhibitors&rft.volume=379&rft.pages=109-111&rft.date=2017&rft.issn=0022-510X&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4765640%23id-name%3DS2CID&rft_id=info%3Apmid%2F28716218&rft_id=info%3Adoi%2F10.1016%2Fj.jns.2017.05.064&rft.aulast=Welk&rft.aufirst=Blayne&rft.au=McArthur%2C+Eric&rft.au=Ordon%2C+Michael&rft.au=Morrow%2C+Sarah+A.&rft.au=Hayward%2C+Jade&rft.au=Dixon%2C+Stephanie&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Drugs.com-Label-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-Drugs.com-Label_23-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/fda/5-alpha-reductase-inhibitors-5-aris-label-change-increased-risk-prostate-cancer-12977.html">"FDA Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer"</a>. Drugs.com. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140714153526/http://www.drugs.com/fda/5-alpha-reductase-inhibitors-5-aris-label-change-increased-risk-prostate-cancer-12977.html">Archived</a> from the original on 2014-07-14<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-06-08</span></span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=FDA+Alert%3A+5-alpha+reductase+inhibitors+%285-ARIs%29%3A+Label+Change+%E2%80%93+Increased+Risk+of+Prostate+Cancer&rft.pub=Drugs.com&rft_id=https%3A%2F%2Fwww.drugs.com%2Ffda%2F5-alpha-reductase-inhibitors-5-aris-label-change-increased-risk-prostate-cancer-12977.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid21555201-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21555201_24-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWongMak2011" class="citation journal cs1">Wong, A. C. M.; Mak, S. T. (2011). "Finasteride-associated cataract and intraoperative floppy-iris syndrome". <i>Journal of Cataract & Refractive Surgery</i>. <b>37</b> (7): 1351–1354. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jcrs.2011.04.013">10.1016/j.jcrs.2011.04.013</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21555201">21555201</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Cataract+%26+Refractive+Surgery&rft.atitle=Finasteride-associated+cataract+and+intraoperative+floppy-iris+syndrome&rft.volume=37&rft.issue=7&rft.pages=1351-1354&rft.date=2011&rft_id=info%3Adoi%2F10.1016%2Fj.jcrs.2011.04.013&rft_id=info%3Apmid%2F21555201&rft.aulast=Wong&rft.aufirst=A.+C.+M.&rft.au=Mak%2C+S.+T.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid18053919-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18053919_25-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFIssaDagres2007" class="citation journal cs1">Issa, S. A.; Dagres, E. (2007). "Intraoperative floppy-iris syndrome and finasteride intake". <i>Journal of Cataract & Refractive Surgery</i>. <b>33</b> (12): 2142–2143. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jcrs.2007.07.025">10.1016/j.jcrs.2007.07.025</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18053919">18053919</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Cataract+%26+Refractive+Surgery&rft.atitle=Intraoperative+floppy-iris+syndrome+and+finasteride+intake&rft.volume=33&rft.issue=12&rft.pages=2142-2143&rft.date=2007&rft_id=info%3Adoi%2F10.1016%2Fj.jcrs.2007.07.025&rft_id=info%3Apmid%2F18053919&rft.aulast=Issa&rft.aufirst=S.+A.&rft.au=Dagres%2C+E.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid28456011-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28456011_26-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLocciPinna2017" class="citation journal cs1">Locci A, Pinna G (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768">"Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment"</a>. <i>Br. J. Pharmacol</i>. <b>174</b> (19): 3226–3241. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fbph.13843">10.1111/bph.13843</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595768">5595768</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28456011">28456011</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Br.+J.+Pharmacol.&rft.atitle=Neurosteroid+biosynthesis+downregulation+and+changes+in+GABAA+receptor+subunit+composition%3A+A+biomarker+axis+in+stress-induced+cognitive+and+emotional+impairment&rft.volume=174&rft.issue=19&rft.pages=3226-3241&rft.date=2017&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5595768%23id-name%3DPMC&rft_id=info%3Apmid%2F28456011&rft_id=info%3Adoi%2F10.1111%2Fbph.13843&rft.aulast=Locci&rft.aufirst=A&rft.au=Pinna%2C+G&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5595768&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid27475241-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27475241_27-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLiuZhaoLiLi2016" class="citation journal cs1">Liu, L; Zhao, S; Li, F; Li, E; Kang, R; Luo, L; Luo, J; Wan, S; Zhao, Z (September 2016). "Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials". <i>The Journal of Sexual Medicine</i>. <b>13</b> (9): 1297–310. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jsxm.2016.07.006">10.1016/j.jsxm.2016.07.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27475241">27475241</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Sexual+Medicine&rft.atitle=Effect+of+5%CE%B1-Reductase+Inhibitors+on+Sexual+Function%3A+A+Meta-Analysis+and+Systematic+Review+of+Randomized+Controlled+Trials.&rft.volume=13&rft.issue=9&rft.pages=1297-310&rft.date=2016-09&rft_id=info%3Adoi%2F10.1016%2Fj.jsxm.2016.07.006&rft_id=info%3Apmid%2F27475241&rft.aulast=Liu&rft.aufirst=L&rft.au=Zhao%2C+S&rft.au=Li%2C+F&rft.au=Li%2C+E&rft.au=Kang%2C+R&rft.au=Luo%2C+L&rft.au=Luo%2C+J&rft.au=Wan%2C+S&rft.au=Zhao%2C+Z&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Gur2013-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gur2013_28-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGurKadowitz,_PJHellstrom,_WJ2013" class="citation journal cs1">Gur, S; Kadowitz, PJ; Hellstrom, WJ (January 2013). "Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation". <i>Expert Opinion on Drug Safety</i>. <b>12</b> (1): 81–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F14740338.2013.742885">10.1517/14740338.2013.742885</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23173718">23173718</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:11624116">11624116</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Drug+Safety&rft.atitle=Effects+of+5-alpha+reductase+inhibitors+on+erectile+function%2C+sexual+desire+and+ejaculation.&rft.volume=12&rft.issue=1&rft.pages=81-90&rft.date=2013-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11624116%23id-name%3DS2CID&rft_id=info%3Apmid%2F23173718&rft_id=info%3Adoi%2F10.1517%2F14740338.2013.742885&rft.aulast=Gur&rft.aufirst=S&rft.au=Kadowitz%2C+PJ&rft.au=Hellstrom%2C+WJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Tra2011-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tra2011_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tra2011_29-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTraishHassani,_JGuay,_ATZitzmann,_M2011" class="citation journal cs1">Traish, AM; Hassani, J; Guay, AT; Zitzmann, M; Hansen, ML (March 2011). "Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients". <i>The Journal of Sexual Medicine</i>. <b>8</b> (3): 872–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1743-6109.2010.02157.x">10.1111/j.1743-6109.2010.02157.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21176115">21176115</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Sexual+Medicine&rft.atitle=Adverse+side+effects+of+5%CE%B1-reductase+inhibitors+therapy%3A+persistent+diminished+libido+and+erectile+dysfunction+and+depression+in+a+subset+of+patients.&rft.volume=8&rft.issue=3&rft.pages=872-84&rft.date=2011-03&rft_id=info%3Adoi%2F10.1111%2Fj.1743-6109.2010.02157.x&rft_id=info%3Apmid%2F21176115&rft.aulast=Traish&rft.aufirst=AM&rft.au=Hassani%2C+J&rft.au=Guay%2C+AT&rft.au=Zitzmann%2C+M&rft.au=Hansen%2C+ML&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid29697934-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29697934_30-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWangZhaoLuoLi2018" class="citation journal cs1">Wang J, Zhao S, Luo L, Li E, Li X, Zhao Z (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523">"5-alpha Reductase Inhibitors and risk of male breast cancer: a systematic review and meta-analysis"</a>. <i>Int Braz J Urol</i>. <b>44</b> (5): 865–873. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1590%2FS1677-5538.IBJU.2017.0531">10.1590/S1677-5538.IBJU.2017.0531</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523">6237523</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29697934">29697934</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Int+Braz+J+Urol&rft.atitle=5-alpha+Reductase+Inhibitors+and+risk+of+male+breast+cancer%3A+a+systematic+review+and+meta-analysis&rft.volume=44&rft.issue=5&rft.pages=865-873&rft.date=2018&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6237523%23id-name%3DPMC&rft_id=info%3Apmid%2F29697934&rft_id=info%3Adoi%2F10.1590%2FS1677-5538.IBJU.2017.0531&rft.aulast=Wang&rft.aufirst=J&rft.au=Zhao%2C+S&rft.au=Luo%2C+L&rft.au=Li%2C+E&rft.au=Li%2C+X&rft.au=Zhao%2C+Z&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6237523&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid29528971-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid29528971_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid29528971_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLeeCho2018" class="citation journal cs1">Lee JY, Cho KS (May 2018). "Effects of 5-alpha reductase inhibitors: new insights on benefits and harms". <i>Curr Opin Urol</i>. <b>28</b> (3): 288–293. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMOU.0000000000000497">10.1097/MOU.0000000000000497</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29528971">29528971</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4587434">4587434</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Curr+Opin+Urol&rft.atitle=Effects+of+5-alpha+reductase+inhibitors%3A+new+insights+on+benefits+and+harms&rft.volume=28&rft.issue=3&rft.pages=288-293&rft.date=2018-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4587434%23id-name%3DS2CID&rft_id=info%3Apmid%2F29528971&rft_id=info%3Adoi%2F10.1097%2FMOU.0000000000000497&rft.aulast=Lee&rft.aufirst=JY&rft.au=Cho%2C+KS&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Traish2018-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Traish2018_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Traish2018_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTraish2018" class="citation journal cs1">Traish, Abdulmaged M. (2018). "The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption". <i>Current Sexual Health Reports</i>. <b>10</b> (3): 88–103. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11930-018-0161-6">10.1007/s11930-018-0161-6</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1548-3584">1548-3584</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:81560714">81560714</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Sexual+Health+Reports&rft.atitle=The+Post-finasteride+Syndrome%3A+Clinical+Manifestation+of+Drug-Induced+Epigenetics+Due+to+Endocrine+Disruption&rft.volume=10&rft.issue=3&rft.pages=88-103&rft.date=2018&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A81560714%23id-name%3DS2CID&rft.issn=1548-3584&rft_id=info%3Adoi%2F10.1007%2Fs11930-018-0161-6&rft.aulast=Traish&rft.aufirst=Abdulmaged+M.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid30651009-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid30651009_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid30651009_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMaksymKajdyRabijewski2019" class="citation journal cs1">Maksym RB, Kajdy A, Rabijewski M (January 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13685538.2018.1548589">"Post-finasteride syndrome - does it really exist?"</a>. <i>Aging Male</i>. <b>22</b> (4): 250–259. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13685538.2018.1548589">10.1080/13685538.2018.1548589</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30651009">30651009</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:58569946">58569946</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Aging+Male&rft.atitle=Post-finasteride+syndrome+-+does+it+really+exist%3F&rft.volume=22&rft.issue=4&rft.pages=250-259&rft.date=2019-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A58569946%23id-name%3DS2CID&rft_id=info%3Apmid%2F30651009&rft_id=info%3Adoi%2F10.1080%2F13685538.2018.1548589&rft.aulast=Maksym&rft.aufirst=RB&rft.au=Kajdy%2C+A&rft.au=Rabijewski%2C+M&rft_id=https%3A%2F%2Fdoi.org%2F10.1080%252F13685538.2018.1548589&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid28319227-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28319227_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28319227_34-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid28319227_34-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFThielke2017" class="citation journal cs1">Thielke S (2017). "The Risk of Suicidality and Depression From 5-α Reductase Inhibitors". <i>JAMA Intern Med</i>. <b>177</b> (5): 691–692. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamainternmed.2017.0096">10.1001/jamainternmed.2017.0096</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28319227">28319227</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA+Intern+Med&rft.atitle=The+Risk+of+Suicidality+and+Depression+From+5-%CE%B1+Reductase+Inhibitors&rft.volume=177&rft.issue=5&rft.pages=691-692&rft.date=2017&rft_id=info%3Adoi%2F10.1001%2Fjamainternmed.2017.0096&rft_id=info%3Apmid%2F28319227&rft.aulast=Thielke&rft.aufirst=S&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid29449167-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29449167_35-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMaldeCartwrightTikkinen2018" class="citation journal cs1">Malde S, Cartwright R, Tikkinen KA (January 2018). "What's New in Epidemiology?". <i>Eur Urol Focus</i>. <b>4</b> (1): 11–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.euf.2018.02.003">10.1016/j.euf.2018.02.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29449167">29449167</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Eur+Urol+Focus&rft.atitle=What%27s+New+in+Epidemiology%3F&rft.volume=4&rft.issue=1&rft.pages=11-13&rft.date=2018-01&rft_id=info%3Adoi%2F10.1016%2Fj.euf.2018.02.003&rft_id=info%3Apmid%2F29449167&rft.aulast=Malde&rft.aufirst=S&rft.au=Cartwright%2C+R&rft.au=Tikkinen%2C+KA&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-:1-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-:1_36-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAndersson2001" class="citation journal cs1">Andersson, S. (July 2001). "Steroidogenic enzymes in skin". <i>European Journal of Dermatology</i>. <b>11</b> (4): 293–295. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1167-1122">1167-1122</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11399532">11399532</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Journal+of+Dermatology&rft.atitle=Steroidogenic+enzymes+in+skin&rft.volume=11&rft.issue=4&rft.pages=293-295&rft.date=2001-07&rft_id=info%3Apmid%2F11399532&rft.issn=1167-1122&rft.aulast=Andersson&rft.aufirst=S.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid16834758-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16834758_37-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFinnBeadles-BohlingBeckleyFord2006" class="citation journal cs1">Finn, Deborah A.; Beadles-Bohling, Amy S.; Beckley, Ethan H.; Ford, Matthew M.; Gililland, Katherine R.; Gorin-Meyer, Rebecca E.; Wiren, Kristine M. (2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762">"A new look at the 5alpha-reductase inhibitor finasteride"</a>. <i>CNS Drug Reviews</i>. <b>12</b> (1): 53–76. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1527-3458.2006.00053.x">10.1111/j.1527-3458.2006.00053.x</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1080-563X">1080-563X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762">6741762</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16834758">16834758</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=CNS+Drug+Reviews&rft.atitle=A+new+look+at+the+5alpha-reductase+inhibitor+finasteride&rft.volume=12&rft.issue=1&rft.pages=53-76&rft.date=2006&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6741762%23id-name%3DPMC&rft.issn=1080-563X&rft_id=info%3Apmid%2F16834758&rft_id=info%3Adoi%2F10.1111%2Fj.1527-3458.2006.00053.x&rft.aulast=Finn&rft.aufirst=Deborah+A.&rft.au=Beadles-Bohling%2C+Amy+S.&rft.au=Beckley%2C+Ethan+H.&rft.au=Ford%2C+Matthew+M.&rft.au=Gililland%2C+Katherine+R.&rft.au=Gorin-Meyer%2C+Rebecca+E.&rft.au=Wiren%2C+Kristine+M.&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6741762&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFinnBeadles-BohlingBeckleyFord2006" class="citation journal cs1">Finn, D. A.; Beadles-Bohling, A. S.; Beckley, E. H.; Ford, M. M.; Gililland, K. R.; Gorin-Meyer, R. E.; Wiren, K. M. (2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762">"A New Look at the 5?-Reductase Inhibitor Finasteride"</a>. <i>CNS Drug Reviews</i>. <b>12</b> (1): 53–76. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1527-3458.2006.00053.x">10.1111/j.1527-3458.2006.00053.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741762">6741762</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16834758">16834758</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=CNS+Drug+Reviews&rft.atitle=A+New+Look+at+the+5%3F-Reductase+Inhibitor+Finasteride&rft.volume=12&rft.issue=1&rft.pages=53-76&rft.date=2006&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6741762%23id-name%3DPMC&rft_id=info%3Apmid%2F16834758&rft_id=info%3Adoi%2F10.1111%2Fj.1527-3458.2006.00053.x&rft.aulast=Finn&rft.aufirst=D.+A.&rft.au=Beadles-Bohling%2C+A.+S.&rft.au=Beckley%2C+E.+H.&rft.au=Ford%2C+M.+M.&rft.au=Gililland%2C+K.+R.&rft.au=Gorin-Meyer%2C+R.+E.&rft.au=Wiren%2C+K.+M.&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6741762&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Cort-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cort_39-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWeinsteinKandalaftRitchCamras1991" class="citation journal cs1">Weinstein BI, Kandalaft N, Ritch R, Camras CB, Morris DJ, Latif SA, Vecsei P, Vittek J, Gordon GG, Southren AL (June 1991). "5 alpha-dihydrocortisol in human aqueous humor and metabolism of cortisol by human lenses in vitro". <i>Invest. Ophthalmol. Vis. Sci</i>. <b>32</b> (7): 2130–5. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2055703">2055703</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Invest.+Ophthalmol.+Vis.+Sci.&rft.atitle=5+alpha-dihydrocortisol+in+human+aqueous+humor+and+metabolism+of+cortisol+by+human+lenses+in+vitro&rft.volume=32&rft.issue=7&rft.pages=2130-5&rft.date=1991-06&rft_id=info%3Apmid%2F2055703&rft.aulast=Weinstein&rft.aufirst=BI&rft.au=Kandalaft%2C+N&rft.au=Ritch%2C+R&rft.au=Camras%2C+CB&rft.au=Morris%2C+DJ&rft.au=Latif%2C+SA&rft.au=Vecsei%2C+P&rft.au=Vittek%2C+J&rft.au=Gordon%2C+GG&rft.au=Southren%2C+AL&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Kenyon_1983-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kenyon_1983_40-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKenyonBremMcDermottDeconti1983" class="citation journal cs1">Kenyon CJ, Brem AS, McDermott MJ, Deconti GA, Latif SA, Morris DJ (May 1983). "Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone". <i>Endocrinology</i>. <b>112</b> (5): 1852–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fendo-112-5-1852">10.1210/endo-112-5-1852</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6403339">6403339</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Endocrinology&rft.atitle=Antinatriuretic+and+kaliuretic+activities+of+the+reduced+derivatives+of+aldosterone&rft.volume=112&rft.issue=5&rft.pages=1852-6&rft.date=1983-05&rft_id=info%3Adoi%2F10.1210%2Fendo-112-5-1852&rft_id=info%3Apmid%2F6403339&rft.aulast=Kenyon&rft.aufirst=CJ&rft.au=Brem%2C+AS&rft.au=McDermott%2C+MJ&rft.au=Deconti%2C+GA&rft.au=Latif%2C+SA&rft.au=Morris%2C+DJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid914969-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid914969_41-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMilewichGomez-SanchezCrowleyPorter1977" class="citation journal cs1">Milewich L, Gomez-Sanchez C, Crowley G, Porter JC, Madden JD, MacDonald PC (October 1977). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-45-4-617">"Progesterone and 5alpha-pregnane-3,20-dione in peripheral blood of normal young women: Daily measurements throughout the menstrual cycle"</a>. <i>J. Clin. Endocrinol. Metab</i>. <b>45</b> (4): 617–22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-45-4-617">10.1210/jcem-45-4-617</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/914969">914969</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=J.+Clin.+Endocrinol.+Metab.&rft.atitle=Progesterone+and+5alpha-pregnane-3%2C20-dione+in+peripheral+blood+of+normal+young+women%3A+Daily+measurements+throughout+the+menstrual+cycle&rft.volume=45&rft.issue=4&rft.pages=617-22&rft.date=1977-10&rft_id=info%3Adoi%2F10.1210%2Fjcem-45-4-617&rft_id=info%3Apmid%2F914969&rft.aulast=Milewich&rft.aufirst=L&rft.au=Gomez-Sanchez%2C+C&rft.au=Crowley%2C+G&rft.au=Porter%2C+JC&rft.au=Madden%2C+JD&rft.au=MacDonald%2C+PC&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fjcem-45-4-617&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAndersson2001" class="citation journal cs1">Andersson, S. (2001). "Steroidogenic enzymes in skin". <i>European Journal of Dermatology</i>. <b>11</b> (4): 293–295. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11399532">11399532</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Journal+of+Dermatology&rft.atitle=Steroidogenic+enzymes+in+skin&rft.volume=11&rft.issue=4&rft.pages=293-295&rft.date=2001&rft_id=info%3Apmid%2F11399532&rft.aulast=Andersson&rft.aufirst=S.&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-BurgerAbraham2003-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-BurgerAbraham2003_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BurgerAbraham2003_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAlfred_BurgerDonald_J._Abraham2003" class="citation book cs1">Alfred Burger; Donald J. Abraham (20 February 2003). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=25ZUAAAAMAAJ"><i>Burger's Medicinal Chemistry and Drug Discovery, Autocoids, Diagnostics, and Drugs from New Biology</i></a>. Wiley. p. 439. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-471-37030-7" title="Special:BookSources/978-0-471-37030-7"><bdi>978-0-471-37030-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230110031744/https://books.google.com/books?id=25ZUAAAAMAAJ">Archived</a> from the original on 10 January 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">24 December</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Burger%27s+Medicinal+Chemistry+and+Drug+Discovery%2C+Autocoids%2C+Diagnostics%2C+and+Drugs+from+New+Biology&rft.pages=439&rft.pub=Wiley&rft.date=2003-02-20&rft.isbn=978-0-471-37030-7&rft.au=Alfred+Burger&rft.au=Donald+J.+Abraham&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D25ZUAAAAMAAJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Llewellyn2011-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Llewellyn2011_44-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWilliam_Llewellyn2011" class="citation book cs1">William Llewellyn (2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971"><i>Anabolics</i></a>. Molecular Nutrition Llc. pp. 968–, 971–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-9828280-1-4" title="Special:BookSources/978-0-9828280-1-4"><bdi>978-0-9828280-1-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230112145743/https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971">Archived</a> from the original on 2023-01-12<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-12-24</span></span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Anabolics&rft.pages=968-%2C+971-&rft.pub=Molecular+Nutrition+Llc&rft.date=2011&rft.isbn=978-0-9828280-1-4&rft.au=William+Llewellyn&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DafKLA-6wW0oC%26pg%3DPT971&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-MacDonald-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-MacDonald_45-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMacDonald2015" class="citation web cs1">MacDonald, Gareth (3 December 2015). <a rel="nofollow" class="external text" href="http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt">"GSK Japan delays alopecia drug launch after Catalent manufacturing halt"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161001165059/http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt">Archived</a> from the original on 1 October 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">24 December</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=GSK+Japan+delays+alopecia+drug+launch+after+Catalent+manufacturing+halt&rft.date=2015-12-03&rft.aulast=MacDonald&rft.aufirst=Gareth&rft_id=http%3A%2F%2Fwww.in-pharmatechnologist.com%2FRegulatory-Safety%2FGSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-SataloffSclafani2015-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-SataloffSclafani2015_46-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRobert_T_SataloffAnthony_P_Sclafani2015" class="citation book cs1">Robert T Sataloff; Anthony P Sclafani (30 November 2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400"><i>Sataloff's Comprehensive Textbook of Otolaryngology: Head & Neck Surgery: Facial Plastic and Reconstructive Surgery</i></a>. JP Medical Ltd. pp. 400–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-93-5152-459-5" title="Special:BookSources/978-93-5152-459-5"><bdi>978-93-5152-459-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230110031702/https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400">Archived</a> from the original on 10 January 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">24 December</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Sataloff%27s+Comprehensive+Textbook+of+Otolaryngology%3A+Head+%26+Neck+Surgery%3A+Facial+Plastic+and+Reconstructive+Surgery&rft.pages=400-&rft.pub=JP+Medical+Ltd&rft.date=2015-11-30&rft.isbn=978-93-5152-459-5&rft.au=Robert+T+Sataloff&rft.au=Anthony+P+Sclafani&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DacswCwAAQBAJ%26pg%3DPA400&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-Drugs.com-Dutasteride-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Drugs.com-Dutasteride_47-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/availability/generic-avodart.html">"Generic Avodart Availability"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161220231141/https://www.drugs.com/availability/generic-avodart.html">Archived</a> from the original on 2016-12-20<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-12-24</span></span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Generic+Avodart+Availability&rft_id=https%3A%2F%2Fwww.drugs.com%2Favailability%2Fgeneric-avodart.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid15138573-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15138573_48-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWangMencherMcCarronFerrari2004" class="citation journal cs1">Wang LG, Mencher SK, McCarron JP, Ferrari AC (2004). "The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review". <i>Oncology Reports</i>. <b>11</b> (6): 1325–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3892%2For.11.6.1325">10.3892/or.11.6.1325</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15138573">15138573</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Oncology+Reports&rft.atitle=The+biological+basis+for+the+use+of+an+anti-androgen+and+a+5-alpha-reductase+inhibitor+in+the+treatment+of+recurrent+prostate+cancer%3A+Case+report+and+review&rft.volume=11&rft.issue=6&rft.pages=1325-9&rft.date=2004&rft_id=info%3Adoi%2F10.3892%2For.11.6.1325&rft_id=info%3Apmid%2F15138573&rft.aulast=Wang&rft.aufirst=LG&rft.au=Mencher%2C+SK&rft.au=McCarron%2C+JP&rft.au=Ferrari%2C+AC&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid15151957-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15151957_49-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTayKaufmanReganLeibowitz2004" class="citation journal cs1">Tay MH, Kaufman DS, Regan MM, Leibowitz SB, George DJ, Febbo PG, Manola J, Smith MR, Kaplan ID, Kantoff PW, Oh WK (2004). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fannonc%2Fmdh221">"Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate"</a>. <i>Annals of Oncology</i>. <b>15</b> (6): 974–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fannonc%2Fmdh221">10.1093/annonc/mdh221</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15151957">15151957</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Oncology&rft.atitle=Finasteride+and+bicalutamide+as+primary+hormonal+therapy+in+patients+with+advanced+adenocarcinoma+of+the+prostate&rft.volume=15&rft.issue=6&rft.pages=974-8&rft.date=2004&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdh221&rft_id=info%3Apmid%2F15151957&rft.aulast=Tay&rft.aufirst=MH&rft.au=Kaufman%2C+DS&rft.au=Regan%2C+MM&rft.au=Leibowitz%2C+SB&rft.au=George%2C+DJ&rft.au=Febbo%2C+PG&rft.au=Manola%2C+J&rft.au=Smith%2C+MR&rft.au=Kaplan%2C+ID&rft.au=Kantoff%2C+PW&rft.au=Oh%2C+WK&rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fannonc%252Fmdh221&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid16844453-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16844453_50-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMerrickButlerWallnerGalbreath2006" class="citation journal cs1">Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Kurko B (2006). "Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy". <i>Urology</i>. <b>68</b> (1): 116–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.urology.2006.01.061">10.1016/j.urology.2006.01.061</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16844453">16844453</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Urology&rft.atitle=Efficacy+of+neoadjuvant+bicalutamide+and+dutasteride+as+a+cytoreductive+regimen+before+prostate+brachytherapy&rft.volume=68&rft.issue=1&rft.pages=116-20&rft.date=2006&rft_id=info%3Adoi%2F10.1016%2Fj.urology.2006.01.061&rft_id=info%3Apmid%2F16844453&rft.aulast=Merrick&rft.aufirst=GS&rft.au=Butler%2C+WM&rft.au=Wallner%2C+KE&rft.au=Galbreath%2C+RW&rft.au=Allen%2C+ZA&rft.au=Kurko%2C+B&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid19796455-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19796455_51-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSartorGomellaGagnierMelich2009" class="citation journal cs1">Sartor O, Gomella LG, Gagnier P, Melich K, Dann R (2009). "Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design". <i>The Canadian Journal of Urology</i>. <b>16</b> (5): 4806–12. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19796455">19796455</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Canadian+Journal+of+Urology&rft.atitle=Dutasteride+and+bicalutamide+in+patients+with+hormone-refractory+prostate+cancer%3A+the+Therapy+Assessed+by+Rising+PSA+%28TARP%29+study+rationale+and+design&rft.volume=16&rft.issue=5&rft.pages=4806-12&rft.date=2009&rft_id=info%3Apmid%2F19796455&rft.aulast=Sartor&rft.aufirst=O&rft.au=Gomella%2C+LG&rft.au=Gagnier%2C+P&rft.au=Melich%2C+K&rft.au=Dann%2C+R&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid26048455-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid26048455_52-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChuSartorGomellaRudo2015" class="citation journal cs1">Chu FM, Sartor O, Gomella L, Rudo T, Somerville MC, Hereghty B, Manyak MJ (2015). "A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer". <i>European Journal of Cancer</i>. <b>51</b> (12): 1555–69. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejca.2015.04.028">10.1016/j.ejca.2015.04.028</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26048455">26048455</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Journal+of+Cancer&rft.atitle=A+randomised%2C+double-blind+study+comparing+the+addition+of+bicalutamide+with+or+without+dutasteride+to+GnRH+analogue+therapy+in+men+with+non-metastatic+castrate-resistant+prostate+cancer&rft.volume=51&rft.issue=12&rft.pages=1555-69&rft.date=2015&rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2015.04.028&rft_id=info%3Apmid%2F26048455&rft.aulast=Chu&rft.aufirst=FM&rft.au=Sartor%2C+O&rft.au=Gomella%2C+L&rft.au=Rudo%2C+T&rft.au=Somerville%2C+MC&rft.au=Hereghty%2C+B&rft.au=Manyak%2C+MJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid26702991-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid26702991_53-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGaudetVigneaultFosterMeyer2016" class="citation journal cs1">Gaudet M, Vigneault É, Foster W, Meyer F, Martin AG (2016). "Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer". <i>Radiotherapy and Oncology</i>. <b>118</b> (1): 141–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.radonc.2015.11.022">10.1016/j.radonc.2015.11.022</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26702991">26702991</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Radiotherapy+and+Oncology&rft.atitle=Randomized+non-inferiority+trial+of+Bicalutamide+and+Dutasteride+versus+LHRH+agonists+for+prostate+volume+reduction+prior+to+I-125+permanent+implant+brachytherapy+for+prostate+cancer&rft.volume=118&rft.issue=1&rft.pages=141-7&rft.date=2016&rft_id=info%3Adoi%2F10.1016%2Fj.radonc.2015.11.022&rft_id=info%3Apmid%2F26702991&rft.aulast=Gaudet&rft.aufirst=M&rft.au=Vigneault%2C+%C3%89&rft.au=Foster%2C+W&rft.au=Meyer%2C+F&rft.au=Martin%2C+AG&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> <li id="cite_note-pmid27330919-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27330919_54-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDijkstraWitjesRoosVijverberg2016" class="citation journal cs1">Dijkstra S, Witjes WP, Roos EP, Vijverberg PL, Geboers AD, Bruins JL, Smits GA, Vergunst H, Mulders PF (2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485">"The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis"</a>. <i>SpringerPlus</i>. <b>5</b>: 653. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs40064-016-2280-8">10.1186/s40064-016-2280-8</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870485">4870485</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27330919">27330919</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=SpringerPlus&rft.atitle=The+AVOCAT+study%3A+Bicalutamide+monotherapy+versus+combined+bicalutamide+plus+dutasteride+therapy+for+patients+with+locally+advanced+or+metastatic+carcinoma+of+the+prostate-a+long-term+follow-up+comparison+and+quality+of+life+analysis&rft.volume=5&rft.pages=653&rft.date=2016&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4870485%23id-name%3DPMC&rft_id=info%3Apmid%2F27330919&rft_id=info%3Adoi%2F10.1186%2Fs40064-016-2280-8&rft.aulast=Dijkstra&rft.aufirst=S&rft.au=Witjes%2C+WP&rft.au=Roos%2C+EP&rft.au=Vijverberg%2C+PL&rft.au=Geboers%2C+AD&rft.au=Bruins%2C+JL&rft.au=Smits%2C+GA&rft.au=Vergunst%2C+H&rft.au=Mulders%2C+PF&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4870485&rfr_id=info%3Asid%2Fen.wikipedia.org%3A5%CE%B1-Reductase+inhibitor" class="Z3988"></span></span> </li> </ol></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style></div><div role="navigation" class="navbox" aria-labelledby="Pharmacology:_enzyme_inhibition" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Enzyme_inhibition" title="Template:Enzyme inhibition"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Enzyme_inhibition" title="Template talk:Enzyme inhibition"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Enzyme_inhibition" title="Special:EditPage/Template:Enzyme inhibition"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Pharmacology:_enzyme_inhibition" style="font-size:114%;margin:0 4em"><a href="/wiki/Pharmacology" title="Pharmacology">Pharmacology</a>: <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">enzyme inhibition</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Class</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Competitive_inhibition" title="Competitive inhibition">Competitive inhibition</a></li> <li><a href="/wiki/Uncompetitive_inhibitor" class="mw-redirect" title="Uncompetitive inhibitor">Uncompetitive inhibition</a></li> <li><a href="/wiki/Non-competitive_inhibition" title="Non-competitive inhibition">Non-competitive inhibition</a></li> <li><a href="/wiki/Suicide_inhibition" title="Suicide inhibition">Suicide inhibition</a></li> <li><a href="/wiki/Mixed_inhibition" title="Mixed inhibition">Mixed inhibition</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Substrate</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Oxidoreductase" title="Oxidoreductase">Oxidoreductase</a> (EC 1)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>1.1 <a href="/wiki/Aldose_reductase_inhibitor" title="Aldose reductase inhibitor">Aldose reductase</a></li> <li><a href="/wiki/Statin" title="Statin">HMG-CoA reductase</a></li></ul> <ul><li>1.3 <a class="mw-selflink selflink">5α-Reductase</a></li></ul> <ul><li>1.4 <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">Monoamine oxidase</a></li></ul> <ul><li>1.5 <a href="/wiki/Dihydrofolate_reductase_inhibitor" title="Dihydrofolate reductase inhibitor">Dihydrofolate reductase</a></li></ul> <ul><li>1.13 <a href="/wiki/Lipoxygenase_inhibitor" class="mw-redirect" title="Lipoxygenase inhibitor">Lipoxygenase</a></li></ul> <ul><li>1.14 <a href="/wiki/Aromatase_inhibitor" title="Aromatase inhibitor">Aromatase</a></li> <li><a href="/wiki/COX-2_inhibitor" class="mw-redirect" title="COX-2 inhibitor">COX-2</a></li></ul> <ul><li>1.17 <a href="/wiki/Xanthine_oxidase_inhibitor" title="Xanthine oxidase inhibitor">Xanthine oxidase</a></li> <li><a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">Ribonucleotide reductase</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Transferase" title="Transferase">Transferase</a> (EC 2)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>2.1 <a href="/wiki/COMT_inhibitor" class="mw-redirect" title="COMT inhibitor">COMT</a></li> <li><a href="/wiki/Thymidylate_synthase_inhibitor" title="Thymidylate synthase inhibitor">Thymidylate synthase</a></li></ul> <ul><li>2.4 <a href="/wiki/PARP_inhibitor" title="PARP inhibitor">PARP</a></li></ul> <ul><li>2.5 <a href="/wiki/Dihydropteroate_synthase_inhibitor" title="Dihydropteroate synthase inhibitor">Dihydropteroate synthetase</a></li> <li><a href="/wiki/Farnesyltransferase_inhibitor" title="Farnesyltransferase inhibitor">Farnesyltransferase</a></li></ul> <ul><li>2.6 <a href="/wiki/GABA_transaminase_inhibitor" title="GABA transaminase inhibitor">GABA transaminase</a></li></ul> <ul><li>2.7 <a href="/wiki/Nucleotidyltransferase" title="Nucleotidyltransferase">Nucleotidyltransferase</a> <ul><li><a href="/wiki/Integrase_inhibitor" title="Integrase inhibitor">Integrase</a></li> <li><a href="/wiki/Reverse-transcriptase_inhibitor" title="Reverse-transcriptase inhibitor">Reverse transcriptase</a></li></ul></li> <li><a href="/wiki/Protein_kinase_inhibitor" title="Protein kinase inhibitor">Protein kinase</a> <ul><li><a href="/wiki/Tyrosine_kinase_inhibitor" title="Tyrosine kinase inhibitor">Tyrosine kinase</a> <ul><li><a href="/wiki/Janus_kinase_inhibitor" title="Janus kinase inhibitor">Janus kinase</a></li></ul></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hydrolase" title="Hydrolase">Hydrolase</a> (EC 3)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>3.1 <a href="/wiki/Phosphodiesterase_inhibitor" title="Phosphodiesterase inhibitor">Phosphodiesterase</a></li> <li><a href="/wiki/Acetylcholinesterase_inhibitor" title="Acetylcholinesterase inhibitor">Acetylcholinesterase</a></li> <li><a href="/wiki/Ribonuclease_inhibitor" title="Ribonuclease inhibitor">Ribonuclease</a></li></ul> <ul><li>3.2 <a href="/wiki/Polygalacturonase_inhibitor" title="Polygalacturonase inhibitor">Polygalacturonase</a></li> <li><a href="/wiki/Neuraminidase_inhibitor" title="Neuraminidase inhibitor">Neuraminidase</a></li> <li><a href="/wiki/Alpha-glucosidase_inhibitor" title="Alpha-glucosidase inhibitor">Alpha-glucosidase</a></li></ul> <ul><li>3.4 <a href="/wiki/Protease_inhibitor_(pharmacology)" title="Protease inhibitor (pharmacology)">Protease</a>: <a href="/wiki/Exopeptidase_inhibitor" title="Exopeptidase inhibitor">Exopeptidase</a> <ul><li><a href="/wiki/Dipeptidyl_peptidase-4_inhibitor" title="Dipeptidyl peptidase-4 inhibitor">DPP-4</a></li> <li><a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE</a></li></ul></li> <li><a href="/wiki/Endopeptidase_inhibitor" title="Endopeptidase inhibitor">Endopeptidase</a> <ul><li><a href="/wiki/Trypsin_inhibitor" title="Trypsin inhibitor">Trypsin</a></li> <li><a href="/wiki/Renin_inhibitor" title="Renin inhibitor">Renin</a></li></ul></li> <li><i>Mixed</i> <ul><li><a href="/wiki/Enkephalinase_inhibitor" title="Enkephalinase inhibitor">Enkephalinase</a></li> <li><a href="/wiki/Matrix_metalloproteinase_inhibitor" title="Matrix metalloproteinase inhibitor">Matrix metalloproteinase</a></li> <li><a href="/wiki/Oxytocinase_inhibitor" class="mw-redirect" title="Oxytocinase inhibitor">Oxytocinase</a></li></ul></li></ul> <ul><li>3.5 <a href="/wiki/Histone_deacetylase_inhibitor" title="Histone deacetylase inhibitor">Histone deacetylase</a></li> <li><a href="/wiki/Beta-lactamase_inhibitor" class="mw-redirect" title="Beta-lactamase inhibitor">Beta-lactamase</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Lyase" title="Lyase">Lyase</a> (EC 4)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>4.1 <a href="/wiki/Dopa_decarboxylase_inhibitor" class="mw-redirect" title="Dopa decarboxylase inhibitor">Dopa decarboxylase</a></li></ul> <ul><li>4.2 <a href="/wiki/Carbonic_anhydrase_inhibitor" title="Carbonic anhydrase inhibitor">Carbonic anhydrase</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Miscellaneous</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Steroidogenesis_inhibitor" title="Steroidogenesis inhibitor">Steroidogenesis inhibitor</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Drugs_used_in_benign_prostatic_hypertrophy" title="Template:Drugs used in benign prostatic hypertrophy"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Drugs_used_in_benign_prostatic_hypertrophy" title="Template talk:Drugs used in benign prostatic hypertrophy"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Drugs_used_in_benign_prostatic_hypertrophy" title="Special:EditPage/Template:Drugs used in benign prostatic hypertrophy"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="font-size:114%;margin:0 4em">Drugs used in <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a> (<a href="/wiki/ATC_code_G04#G04C" title="ATC code G04">G04C</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a class="mw-selflink selflink">5α-Reductase inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a> (<a href="/wiki/Finasteride/tadalafil" title="Finasteride/tadalafil">+tadalafil</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Alpha-1_blocker" title="Alpha-1 blocker">Alpha-1 blockers</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Alfuzosin" title="Alfuzosin">Alfuzosin</a></li> <li><a href="/wiki/Doxazosin" title="Doxazosin">Doxazosin</a></li> <li><a href="/wiki/Silodosin" title="Silodosin">Silodosin</a></li> <li><a href="/wiki/Tamsulosin" title="Tamsulosin">Tamsulosin</a></li> <li><a href="/wiki/Terazosin" title="Terazosin">Terazosin</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Steroidal_antiandrogen" title="Steroidal antiandrogen">Steroidal antiandrogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li> <li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li> <li><a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">Gestonorone caproate</a></li> <li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li> <li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Herbal_medicine" title="Herbal medicine">Herbal products</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Pygeum_(herbal_remedy)" class="mw-redirect" title="Pygeum (herbal remedy)">Pygeum africanum</a></i></li> <li><i><a href="/wiki/Saw_palmetto_extract" title="Saw palmetto extract">Saw palmetto extract</a></i></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Mepartricin" title="Mepartricin">Mepartricin</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Other_dermatological_preparations_(D11)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Other_dermatological_preparations" title="Template:Other dermatological preparations"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Other_dermatological_preparations" title="Template talk:Other dermatological preparations"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Other_dermatological_preparations" title="Special:EditPage/Template:Other dermatological preparations"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Other_dermatological_preparations_(D11)" style="font-size:114%;margin:0 4em">Other <a href="/wiki/Dermatological" class="mw-redirect" title="Dermatological">dermatological</a> preparations (<a href="/wiki/ATC_code_D11" title="ATC code D11">D11</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anti-seborrheic" title="Anti-seborrheic">Anti-seborrheics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></i> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li> <li><i><a href="/wiki/Antifungal" title="Antifungal">Antifungals</a></i> <ul><li><a href="/wiki/Bifonazole" title="Bifonazole">Bifonazole</a></li> <li><a href="/wiki/Cetrimonium_bromide" title="Cetrimonium bromide">Cetrimonium bromide</a> (<a href="/wiki/Cetrimide" title="Cetrimide">cetrimide</a>)</li> <li><a href="/wiki/Ciclopirox_olamine" class="mw-redirect" title="Ciclopirox olamine">Ciclopirox olamine (ciclopirox)</a></li> <li><a href="/wiki/Climbazole" title="Climbazole">Climbazole</a></li> <li><a href="/wiki/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Miconazole" title="Miconazole">Miconazole</a></li> <li><a href="/wiki/Piroctone_olamine" title="Piroctone olamine">Piroctone olamine</a></li> <li><a href="/wiki/Selenium_disulfide" title="Selenium disulfide">Selenium disulfide (selenium sulfide)</a></li> <li><a href="/w/index.php?title=Xenysalate&action=edit&redlink=1" class="new" title="Xenysalate (page does not exist)">Xenysalate</a></li> <li><a href="/wiki/Zinc_pyrithione" title="Zinc pyrithione">Zinc pyrithione (pyrithione zinc)</a></li></ul></li> <li><i><a href="/wiki/Antihistamine" title="Antihistamine">Antihistamines</a></i></li> <li><i><a href="/wiki/Calcineurin_inhibitor" class="mw-redirect" title="Calcineurin inhibitor">Calcineurin inhibitors</a></i> <ul><li><a href="/wiki/Cyclosporin" class="mw-redirect" title="Cyclosporin">Cyclosporin</a></li> <li><a href="/wiki/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li> <li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul></li> <li><a href="/wiki/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li> <li><i><a href="/wiki/Keratolytic" title="Keratolytic">Keratolytics</a></i> <ul><li><a href="/wiki/Coal_tar" title="Coal tar">Coal tar</a></li> <li><a href="/wiki/Resorcinol" title="Resorcinol">Resorcinol</a></li> <li><a href="/wiki/Salicylic_acid" title="Salicylic acid">Salicylic acid</a></li> <li><a href="/wiki/Sulfur" title="Sulfur">Sulfur</a></li> <li><a href="/wiki/Urea" title="Urea">Urea</a> (<a href="/wiki/Urea-containing_cream" title="Urea-containing cream">urea-containing cream</a>)</li></ul></li> <li><i><a href="/wiki/Lithium_(medication)" title="Lithium (medication)">Lithium salts</a></i> <ul><li><a href="/wiki/Lithium_gluconate" class="mw-redirect" title="Lithium gluconate">Lithium gluconate</a></li> <li><a href="/wiki/Lithium_succinate" title="Lithium succinate">Lithium succinate</a></li></ul></li> <li><i><a href="/wiki/Topical_steroid" title="Topical steroid">Topical corticosteroids</a></i> (e.g., <a href="/wiki/Hydrocortisone" title="Hydrocortisone">hydrocortisone</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Skin_whitening" title="Skin whitening">Skin lightening</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Hydroquinone" title="Hydroquinone">Hydroquinone</a></li> <li><a href="/wiki/Mequinol" title="Mequinol">Mequinol</a></li> <li><a href="/wiki/Monobenzone" title="Monobenzone">Monobenzone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sun_tanning" title="Sun tanning">Skin darkening</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Afamelanotide" title="Afamelanotide">Afamelanotide</a></li> <li><a href="/wiki/Melanotan_II" title="Melanotan II">Melanotan II</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anti-inflammatories" class="mw-redirect" title="Anti-inflammatories">Anti-inflammatories</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li> <li><a href="/wiki/%CE%93-Linolenic_acid" title="Γ-Linolenic acid">Gamolenic acid</a></li> <li><a href="/wiki/Oxaceprol" title="Oxaceprol">Oxaceprol</a></li> <li><a href="/wiki/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li> <li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul> <ul><li><i><a href="/wiki/Topical_steroid" title="Topical steroid">Topical corticosteroids</a></i> (e.g., <a href="/wiki/Hydrocortisone" title="Hydrocortisone">hydrocortisone</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Management_of_hair_loss" title="Management of hair loss">Alopecia treatments</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a class="mw-selflink selflink">5α-Reductase inhibitors</a></i> <ul><li><a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li> <li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li> <li><a href="/wiki/Saw_palmetto_extract" title="Saw palmetto extract">Saw palmetto extract</a></li></ul></li> <li><i><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></i> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li> <li><a href="/wiki/Topilutamide" title="Topilutamide">Topilutamide (fluridil)</a></li></ul></li> <li><i><a href="/wiki/Potassium_channel_opener" title="Potassium channel opener">Potassium channel openers</a></i> <ul><li><a href="/wiki/Minoxidil" title="Minoxidil">Minoxidil</a></li></ul></li> <li><i>Others</i> <ul><li><a href="/wiki/Nepidermin" title="Nepidermin">Nepidermin</a></li> <li><a href="/wiki/Ritlecitinib" title="Ritlecitinib">Ritlecitinib</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hair_growth_inhibitor" class="mw-redirect" title="Hair growth inhibitor">Hair growth inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a class="mw-selflink selflink">5α-Reductase inhibitors</a></i> <ul><li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li></ul></li> <li><i><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></i> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul></li> <li><a href="/wiki/Eflornithine" title="Eflornithine">Eflornithine</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abrocitinib" title="Abrocitinib">Abrocitinib</a></li> <li><a href="/wiki/Aminobenzoate" class="mw-redirect" title="Aminobenzoate">Aminobenzoate potassium</a></li> <li><a href="/wiki/Androgen" title="Androgen">Androgens</a> (e.g., <a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">testosterone</a>)</li> <li><a href="/wiki/Benzoylperoxide" class="mw-redirect" title="Benzoylperoxide">Benzoylperoxide</a></li> <li><a href="/wiki/Brimonidine" title="Brimonidine">Brimonidine</a></li> <li><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a></li> <li><a href="/wiki/Calcium_gluconate" title="Calcium gluconate">Calcium gluconate</a></li> <li><a href="/wiki/Collagen" title="Collagen">Collagen</a></li> <li><a href="/wiki/Crisaborole" title="Crisaborole">Crisaborole</a></li> <li><a href="/wiki/Cromoglicic_acid" title="Cromoglicic acid">Cromoglicic acid</a></li> <li><a href="/wiki/Delgocitinib" title="Delgocitinib">Delgocitinib</a></li> <li><a href="/wiki/Deoxycholic_acid" title="Deoxycholic acid">Deoxycholic acid</a></li> <li><a href="/wiki/Diclofenac" title="Diclofenac">Diclofenac</a></li> <li><a href="/wiki/Dupilumab" title="Dupilumab">Dupilumab</a></li> <li><a href="/wiki/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>)</li> <li><a href="/wiki/Glycopyrronium_bromide" title="Glycopyrronium bromide">Glycopyrronium bromide</a></li> <li><a href="/wiki/Glycopyrronium_tosylate" title="Glycopyrronium tosylate">Glycopyrronium tosylate</a></li> <li><a href="/wiki/Hyaluronic_acid" title="Hyaluronic acid">Hyaluronic acid</a></li> <li><a href="/wiki/Hydrogen_peroxide" title="Hydrogen peroxide">Hydrogen peroxide</a></li> <li><a href="/wiki/Ivermectin" title="Ivermectin">Ivermectin</a></li> <li><a href="/wiki/Lebrikizumab" title="Lebrikizumab">Lebrikizumab</a></li> <li><a href="/wiki/Lokivetmab" title="Lokivetmab">Lokivetmab</a></li> <li><a href="/wiki/Magnesium_sulfate" title="Magnesium sulfate">Magnesium sulfate</a></li> <li><a href="/wiki/Metandienone" title="Metandienone">Metandienone</a></li> <li><a href="/wiki/Nemolizumab" title="Nemolizumab">Nemolizumab</a></li> <li><a href="/wiki/Oclacitinib" title="Oclacitinib">Oclacitinib</a></li> <li><a href="/wiki/Oxymetazoline" title="Oxymetazoline">Oxymetazoline</a></li> <li><a href="/wiki/Povidone-iodine" title="Povidone-iodine">Povidone-iodine</a></li> <li><a href="/wiki/Pregnenolone_acetate" title="Pregnenolone acetate">Pregnenolone acetate</a></li> <li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> (e.g., <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a>)</li> <li><a href="/wiki/Ruxolitinib" title="Ruxolitinib">Ruxolitinib</a></li> <li><a href="/wiki/Tiratricol" title="Tiratricol">Tiratricol</a></li> <li><a href="/wiki/Tralokinumab" title="Tralokinumab">Tralokinumab</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-labelledby="Androgens_and_antiandrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Androgens_and_antiandrogens" title="Template talk:Androgens and antiandrogens"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Androgens_and_antiandrogens" title="Special:EditPage/Template:Androgens and antiandrogens"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Androgens_and_antiandrogens" style="font-size:114%;margin:0 4em"><a href="/wiki/Androgen" title="Androgen">Androgens</a> and <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogens</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Androgen" title="Androgen">Androgens</a><br />(incl. <a href="/wiki/Anabolic%E2%80%93androgenic_steroid" class="mw-redirect" title="Anabolic–androgenic steroid"><abbr title="anabolic–androgenic steroid">AAS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip anabolic–androgenic steroid</span>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Androgen receptor</span> <a href="/wiki/Agonist" title="Agonist">agonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Testosterone derivatives:</i> <a href="/wiki/Androstenediol_dipropionate" title="Androstenediol dipropionate">Androstenediol dipropionate</a></li> <li><a href="/wiki/Boldenone_undecylenate" title="Boldenone undecylenate">Boldenone undecylenate</a></li> <li><a href="/wiki/Clostebol" title="Clostebol">Clostebol</a></li> <li><a href="/wiki/Clostebol_acetate" title="Clostebol acetate">Clostebol acetate</a></li> <li><a href="/wiki/Clostebol_caproate" title="Clostebol caproate">Clostebol caproate</a></li> <li><a href="/wiki/Clostebol_propionate" title="Clostebol propionate">Clostebol propionate</a></li> <li><a href="/wiki/Cloxotestosterone_acetate" title="Cloxotestosterone acetate">Cloxotestosterone acetate</a></li> <li><a href="/wiki/Prasterone" title="Prasterone">Prasterone (dehydroepiandrosterone, DHEA)</a></li> <li><a href="/wiki/Prasterone_enanthate" title="Prasterone enanthate">Prasterone enanthate (DHEA enanthate)</a></li> <li><a href="/wiki/Prasterone_sulfate" title="Prasterone sulfate">Prasterone sulfate (DHEA sulfate)</a></li> <li><a href="/wiki/Quinbolone" title="Quinbolone">Quinbolone</a></li> <li><a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">Testosterone</a><sup>#</sup></li> <li><a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">Testosterone esters</a> (e.g., <a href="/wiki/Testosterone_cypionate" title="Testosterone cypionate">testosterone cypionate</a>, <a href="/wiki/Testosterone_enanthate" title="Testosterone enanthate">testosterone enanthate</a>, <a href="/wiki/Testosterone_propionate" title="Testosterone propionate">testosterone propionate</a>, <a href="/wiki/Testosterone_undecanoate" title="Testosterone undecanoate">testosterone undecanoate</a>, <a href="/wiki/Testosterone_ester_mixture" class="mw-redirect" title="Testosterone ester mixture">testosterone ester mixtures</a> (<a href="/wiki/Deposterona" class="mw-redirect" title="Deposterona">Deposterona</a>, <a href="/wiki/Omnadren" class="mw-redirect" title="Omnadren">Omnadren</a>, <a href="/wiki/Testosterone_propionate/testosterone_phenylpropionate/testosterone_isocaproate/testosterone_decanoate" title="Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate">Sustanon</a>, <a href="/wiki/Testoviron_depot" class="mw-redirect" title="Testoviron depot">Testoviron Depot</a>))</li></ul> <ul><li><i>Dihydrotestosterone derivatives:</i> <a href="/wiki/Androstanolone" title="Androstanolone">Androstanolone (stanolone, dihydrotestosterone, DHT)</a></li> <li><a href="/wiki/List_of_androgen_esters#Dihydrotestosterone_esters" title="List of androgen esters">Androstanolone esters</a></li> <li><a href="/wiki/Bolazine_capronate" title="Bolazine capronate">Bolazine capronate</a></li> <li><a href="/wiki/Drostanolone_propionate" title="Drostanolone propionate">Drostanolone propionate (dromostanolone propionate)</a></li> <li><a href="/wiki/Epitiostanol" title="Epitiostanol">Epitiostanol</a></li> <li><a href="/wiki/Mepitiostane" title="Mepitiostane">Mepitiostane</a></li> <li><a href="/wiki/Mesterolone" title="Mesterolone">Mesterolone</a></li> <li><a href="/wiki/Metenolone_acetate" title="Metenolone acetate">Metenolone acetate (methenolone acetate)</a></li> <li><a href="/wiki/Metenolone_enanthate" title="Metenolone enanthate">Metenolone enanthate (methenolone enanthate)</a></li> <li><a href="/wiki/Stenbolone_acetate" title="Stenbolone acetate">Stenbolone acetate</a></li></ul> <ul><li><i>19-Nortestosterone derivatives:</i> <a href="/wiki/Bolandiol_dipropionate" title="Bolandiol dipropionate">Bolandiol dipropionate</a></li> <li><a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">Nandrolone esters</a> (e.g., <a href="/wiki/Nandrolone_decanoate" title="Nandrolone decanoate">nandrolone decanoate</a>, <a href="/wiki/Nandrolone_phenylpropionate" title="Nandrolone phenylpropionate">nandrolone phenylpropionate</a>)</li> <li><a href="/wiki/Norclostebol" title="Norclostebol">Norclostebol</a></li> <li><a href="/wiki/Norclostebol_acetate" title="Norclostebol acetate">Norclostebol acetate</a></li> <li><a href="/wiki/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li> <li><a href="/wiki/Trenbolone_acetate" title="Trenbolone acetate">Trenbolone acetate</a></li> <li><a href="/wiki/Trenbolone_hexahydrobenzylcarbonate" title="Trenbolone hexahydrobenzylcarbonate">Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)</a></li></ul> <ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="/wiki/Bolasterone" title="Bolasterone">Bolasterone</a></li> <li><a href="/wiki/Calusterone" title="Calusterone">Calusterone</a></li> <li><a href="/wiki/Chlorodehydromethyltestosterone" title="Chlorodehydromethyltestosterone">Chlorodehydromethyltestosterone (CDMT)</a></li> <li><a href="/wiki/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li> <li><a href="/wiki/Formebolone" title="Formebolone">Formebolone</a></li> <li><a href="/wiki/Metandienone" title="Metandienone">Metandienone (methandienone, methandrostenolone)</a></li> <li><a href="/wiki/Methandriol" title="Methandriol">Methandriol (methylandrostenediol)</a></li> <li><a href="/wiki/Methandriol_bisenanthoyl_acetate" title="Methandriol bisenanthoyl acetate">Methandriol bisenanthoyl acetate</a></li> <li><a href="/wiki/Methandriol_dipropionate" title="Methandriol dipropionate">Methandriol dipropionate</a></li> <li><a href="/wiki/Methandriol_propionate" title="Methandriol propionate">Methandriol propionate</a></li> <li><a href="/wiki/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a></li> <li><a href="/wiki/Methyltestosterone_3-hexyl_ether" title="Methyltestosterone 3-hexyl ether">Methyltestosterone 3-hexyl ether</a></li> <li><a href="/wiki/Oxymesterone" title="Oxymesterone">Oxymesterone</a></li> <li><a href="/wiki/Penmesterol" title="Penmesterol">Penmesterol</a></li> <li><a href="/wiki/Tiomesterone" title="Tiomesterone">Tiomesterone (thiomesterone)</a></li></ul> <ul><li><i>17α-Alkylated dihydrotestosterone derivatives:</i> <a href="/wiki/Androisoxazole" title="Androisoxazole">Androisoxazole</a></li> <li><a href="/wiki/Furazabol" title="Furazabol">Furazabol</a></li> <li><a href="/wiki/Mebolazine" title="Mebolazine">Mebolazine (dimethazine)</a></li> <li><a href="/wiki/Mestanolone" title="Mestanolone">Mestanolone</a></li> <li><a href="/wiki/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li> <li><a href="/wiki/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li> <li><a href="/wiki/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul> <ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="/wiki/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li> <li><a href="/wiki/Mibolerone" title="Mibolerone">Mibolerone</a></li> <li><a href="/wiki/Norethandrolone" title="Norethandrolone">Norethandrolone</a></li> <li><a href="/wiki/Normethandrone" title="Normethandrone">Normethandrone (methylestrenolone, normethisterone)</a></li> <li><a href="/wiki/Propetandrol" title="Propetandrol">Propetandrol (propethandrol)</a></li></ul> <ul><li><i>17α-Vinyltestosterone derivatives:</i> <a href="/wiki/Norvinisterone" title="Norvinisterone">Norvinisterone (vinylnortestosterone)</a></li></ul> <ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="/wiki/Danazol" title="Danazol">Danazol</a></li> <li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li> <li><a href="/wiki/Progestin" class="mw-redirect" title="Progestin">Progestins</a> (e.g., <a href="/wiki/Ethisterone" title="Ethisterone">ethisterone (ethynyltestosterone)</a>, <a href="/wiki/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a>, <a href="/wiki/Norgestrel" title="Norgestrel">norgestrel</a>, <a href="/wiki/Norethisterone" title="Norethisterone">norethisterone (norethindrone)</a>, <a href="/wiki/Lynestrenol" title="Lynestrenol">lynestrenol</a>, <a href="/wiki/Norgestrienone" title="Norgestrienone">norgestrienone</a>)</li> <li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li></ul> <ul><li><i>Progesterone derivatives:</i> <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Progonadotropin" title="Progonadotropin">Progonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Antiestrogen" title="Antiestrogen">Antiestrogens</a> (e.g., <a href="/wiki/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="/wiki/Clomifene" title="Clomifene">clomifene</a>)</li> <li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist">GnRH agonists</a> (e.g., <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH (gonadorelin)</a>, <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li> <li><a href="/wiki/Gonadotropin" title="Gonadotropin">Gonadotropins</a> (e.g., <a href="/wiki/Luteinizing_hormone" title="Luteinizing hormone"><abbr title="luteinizing hormone">LH</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip luteinizing hormone</span>, <a href="/wiki/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin"><abbr title="human chorionic gonadotropin">hCG</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip human chorionic gonadotropin</span>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Androgen receptor</span> <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a> <a href="/wiki/Niraparib/abiraterone_acetate" title="Niraparib/abiraterone acetate">+niraparib</a></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li> <li><a href="/wiki/Dienogest" title="Dienogest">Dienogest</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li> <li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li> <li><a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a></li> <li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li> <li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li> <li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/Apalutamide" title="Apalutamide">Apalutamide</a></li> <li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cimetidine" title="Cimetidine">Cimetidine</a></li> <li><a href="/wiki/Darolutamide" title="Darolutamide">Darolutamide</a></li> <li><a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li> <li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a><sup>†</sup></li> <li><a href="/wiki/Topilutamide" title="Topilutamide">Topilutamide (fluridil)</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Steroidogenesis_inhibitor" title="Steroidogenesis inhibitor">Steroidogenesis<br />inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a class="mw-selflink selflink">5α-Reductase</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li> <li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li> <li><a href="/wiki/Saw_palmetto_extract" title="Saw palmetto extract">Saw palmetto extract</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a> <a href="/wiki/Niraparib/abiraterone_acetate" title="Niraparib/abiraterone acetate">+niraparib</a></li> <li><a href="/wiki/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li> <li><a href="/wiki/Bifluranol" title="Bifluranol">Bifluranol</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li> <li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a><sup>†</sup></li> <li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Antigonadotropin" title="Antigonadotropin">Antigonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/D2_receptor" class="mw-redirect" title="D2 receptor">D<sub>2</sub> receptor</a> <a href="/wiki/Dopamine_antagonist" title="Dopamine antagonist">antagonists</a> (<a href="/wiki/Prolactin_releaser" class="mw-redirect" title="Prolactin releaser">prolactin releasers</a>) (e.g., <a href="/wiki/Domperidone" title="Domperidone">domperidone</a>, <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Sulpiride" title="Sulpiride">sulpiride</a>)</li> <li><a href="/wiki/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="/wiki/Bifluranol" title="Bifluranol">bifluranol</a>, <a href="/wiki/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>, <a href="/wiki/List_of_estrogen_esters#Estradiol_esters" title="List of estrogen esters">estradiol esters</a>, <a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">ethinylestradiol</a>, <a href="/wiki/Ethinylestradiol_sulfonate" title="Ethinylestradiol sulfonate">ethinylestradiol sulfonate</a>, <a href="/wiki/Paroxypropione" title="Paroxypropione">paroxypropione</a>)</li> <li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist">GnRH agonists</a> (e.g., <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li> <li><a href="/wiki/GnRH_antagonist" class="mw-redirect" title="GnRH antagonist">GnRH antagonists</a> (e.g., <a href="/wiki/Cetrorelix" title="Cetrorelix">cetrorelix</a>)</li> <li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> (incl., <a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">chlormadinone acetate</a>, <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a>, <a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">hydroxyprogesterone caproate</a>, <a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">gestonorone caproate</a>, <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, <a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Androstenedione immunogens:</i> <a href="/wiki/Androvax" title="Androvax">Androvax (androstenedione albumin)</a></li> <li><a href="/wiki/Ovandrotone_albumin" title="Ovandrotone albumin">Ovandrotone albumin (Fecundin)</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist"> <ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li><sup>§</sup>Never to phase III</li></ul></li></ul> </div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Androgen_receptor_modulators" title="Template:Androgen receptor modulators">Androgen receptor modulators</a></dd> <dd><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens">Estrogens and antiestrogens</a></dd> <dd><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens">Progestogens and antiprogestogens</a></dd> <dd><a href="/wiki/List_of_androgens/anabolic_steroids" class="mw-redirect" title="List of androgens/anabolic steroids">List of androgens/anabolic steroids</a></dd></dl></div></td></tr></tbody></table></div> <!-- NewPP limit report Parsed by mw‐api‐ext.codfw.main‐6dc4bd494b‐srtxp Cached time: 20241212140534 Cache expiry: 2592000 Reduced expiry: false Complications: [vary‐revision‐sha1, show‐toc] CPU time usage: 0.734 seconds Real time usage: 0.865 seconds Preprocessor visited node count: 4298/1000000 Post‐expand include size: 239774/2097152 bytes Template argument size: 2287/2097152 bytes Highest expansion depth: 16/100 Expensive parser function count: 1/500 Unstrip recursion depth: 1/20 Unstrip post‐expand size: 254492/5000000 bytes Lua time usage: 0.427/10.000 seconds Lua memory usage: 6299659/52428800 bytes Number of Wikibase entities loaded: 0/400 --> <!-- Transclusion expansion time report (%,ms,calls,template) 100.00% 703.144 1 -total 57.13% 401.675 1 Template:Reflist 27.29% 191.889 39 Template:Cite_journal 16.50% 116.013 8 Template:Cite_book 11.61% 81.643 8 Template:Navbox 9.61% 67.569 1 Template:Short_description 7.83% 55.028 1 Template:5α-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use 7.30% 51.347 1 Template:Infobox_drug_class 7.09% 49.828 1 Template:Navbar 6.87% 48.332 1 Template:Infobox --> <!-- Saved in parser cache with key enwiki:pcache:1284673:|#|:idhash:canonical and timestamp 20241212140613 and revision id 1262650612. Rendering was triggered because: edit-page --> </div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?useformat=desktop&type=1x1&usesul3=0" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=5α-Reductase_inhibitor&oldid=1262650612">https://en.wikipedia.org/w/index.php?title=5α-Reductase_inhibitor&oldid=1262650612</a>"</div></div> <div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:5%CE%B1-Reductase_inhibitors" title="Category:5α-Reductase inhibitors">5α-Reductase inhibitors</a></li><li><a href="/wiki/Category:Hair_loss_medications" title="Category:Hair loss medications">Hair loss medications</a></li><li><a href="/wiki/Category:Hair_removal" title="Category:Hair removal">Hair removal</a></li><li><a href="/wiki/Category:Antiandrogens" title="Category:Antiandrogens">Antiandrogens</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li></ul></div></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> <li id="footer-info-lastmod"> This page was last edited on 12 December 2024, at 14:05<span class="anonymous-show"> (UTC)</span>.</li> <li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>; additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=5%CE%B1-Reductase_inhibitor&mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://wikimediafoundation.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/static/images/footer/wikimedia-button.svg" width="84" height="29" alt="Wikimedia Foundation" loading="lazy"></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/w/resources/assets/poweredby_mediawiki.svg" alt="Powered by MediaWiki" width="88" height="31" loading="lazy"></a></li> </ul> </footer> </div> </div> </div> <div class="vector-settings" id="p-dock-bottom"> <ul></ul> </div><script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-746fb5b8df-xdvvj","wgBackendResponseTime":136,"wgPageParseReport":{"limitreport":{"cputime":"0.734","walltime":"0.865","ppvisitednodes":{"value":4298,"limit":1000000},"postexpandincludesize":{"value":239774,"limit":2097152},"templateargumentsize":{"value":2287,"limit":2097152},"expansiondepth":{"value":16,"limit":100},"expensivefunctioncount":{"value":1,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":254492,"limit":5000000},"entityaccesscount":{"value":0,"limit":400},"timingprofile":["100.00% 703.144 1 -total"," 57.13% 401.675 1 Template:Reflist"," 27.29% 191.889 39 Template:Cite_journal"," 16.50% 116.013 8 Template:Cite_book"," 11.61% 81.643 8 Template:Navbox"," 9.61% 67.569 1 Template:Short_description"," 7.83% 55.028 1 Template:5α-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use"," 7.30% 51.347 1 Template:Infobox_drug_class"," 7.09% 49.828 1 Template:Navbar"," 6.87% 48.332 1 Template:Infobox"]},"scribunto":{"limitreport-timeusage":{"value":"0.427","limit":"10.000"},"limitreport-memusage":{"value":6299659,"limit":52428800}},"cachereport":{"origin":"mw-api-ext.codfw.main-6dc4bd494b-srtxp","timestamp":"20241212140534","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"5\u03b1-Reductase inhibitor","url":"https:\/\/en.wikipedia.org\/wiki\/5%CE%B1-Reductase_inhibitor","sameAs":"http:\/\/www.wikidata.org\/entity\/Q4639645","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q4639645","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-12-16T08:55:16Z","dateModified":"2024-12-12T14:05:34Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/2\/21\/Dutasteride.svg","headline":"class of medications with antiandrogenic effects used primarily in the treatment of enlarged prostate and scalp hair loss"}</script> </body> </html>